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Abstract 
Bifidobacteria are a major microbial component of infant gut microbiota which is believed to 
promote health benefits for the host and stimulate the maturation of immune system. Despite 
the importance we know little about the natural development of bifidobacteria in the infant 
gut. To address this question, we analyzed mixed Bifidobacterium clpC gene sequences from 
IMPACT (Immunology and Microbiology in Prevention of Allergy among Children in 
Trondheim) stool samples of 83 infants and their mothers using the novel multivariate 
statistical MCR-ALS approach. We also developed a novel basecaller script in MATLAB
®
 
environment which simplifies the use of the MCR-ALS method so that manual decoding is no 
longer required. Faecal material was sampled during the first and the second part of 
pregnancy, at 3 days, 10 days, 4 months, 1 year and 2 years after birth. Five dominant 
Bifidobacterium species were identified and verified by cloning. Stool samples were predicted 
to be rich in B. adolescentis, B. bifidum, B. dentium, B. breve and B. longum species. The B. 
longum group consisted of B. longum longum irrespective of age, however B. longum infantis 
was mostly identified in four-month-old individuals indicating a potential infant-to-infant 
nature of its transmittance. Local Similarity Analysis revealed self-supportive correlations 
between Bifidobacterium, Lactobacillales, Clostridium, Proteobacteria and other bacterial 
groups. The amount of B. breve in infants correlated with the incidence of common cold 
infections during pregnancy. Development of all Bifidobacterium and B. longum groups had 
correlation to the occurrence of vaginal fungal infection during pregnancy. Elevated amounts 
of B. adolescentis in four-month-old infants correlated to high IgE levels and eczema 
symptoms, while levels of the B. longum group in infants – to eczema. In conclusion, new 
patterns in bifidobacterial development and interaction are described. We believe this new 
knowledge will be important for the future understanding of bifidobacteria in health and 
disease. 
Keywords: Bifidobacterium, clpC, mixed sequence, MCR-ALS, interaction, cold, fungi 
infection, IgE, eczema 
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1 Introduction 
1.1 Gut microbiota 
Our gastro intestinal tract (GIT) is a habitat for more than 10
14
 microbial cells, which 
outnumber human cells in the entire body by at least one order of magnitude. Humans are 
born germ-free, but right from the delivery and soon thereafter our guts become densely 
colonized by various bacteria. The colonization pattern is influenced greatly by various 
factors including manner of delivery, infant diet, antibiotic use and hygiene (Wall R. et al., 
2009). During early days of life, infant stool samples are rich in facultative anaerobic 
Proteobacteria. Later on, when oxygen levels decrease, anaerobic species belonging to 
Bacteroides, Clostridium and Bifidobacterium colonize the gut (Marques et al., 2010). The 
bacterial composition in the gut becomes similar to that of adults by the age of one year, and 
then it remains rather stable (Palmer C. et al., 2007). Usually, adult microbiota is dominated 
by Firmicutes and Bacteroidetes which make up to 98 % of all 16S rRNA sequences isolated 
from intestinal samples. The other phyla associated with the human gut are Proteobacteria, 
Actinobacteria, Fusobacteria, Verrucomicrobia and Cyanobacteria (Ley R. et al., 2006). It is 
still not certain how many species reside in our guts and the suggested numbers range from 
500 (Hattori M., Taylor T., 2009) up to 12 000 – 36 000 different species (Brugere J. et al., 
2009). Such a discrepancy results from the fact that most of the intestinal microbes are strict 
anaerobes which have never been cultured – even with new culture-independent methods in 
hand, more than 80 % of the intestinal microbiota has not yet been taxonomically 
characterized (Fliss I. et al., 2010). All together, intestinal microbiota constitutes 
approximately 2 % of our biomass and its collective genome has 100 times more genes than 
the human genome (Brugere J. et al., 2009). The majority of human gut microbiota consists of 
bacterial cells; however, some fungi and archaea, mostly represented by Methanobrevibacter 
smithii, are also found in the gut (Eckburg P. et al., 2005). Generally, on a species level, 
microbial communities within our colons are as unique as a fingerprint (Dethlefsen L. et al., 
2007), even though possibly being influenced by host genetics to a certain extent. For 
example, the composition of intestinal species between monozygotic twins who had not been 
living together for more than 5 years was found closer to each other than to their respective 
marital partners, but still unique for each twin (Zoetendal E. et al., 2001).  
 10 
 
Despite the huge individual variation of intestinal species, gut microbiota seems to be more 
stable functionally (Stecher B. et al., 2010). At the same time, it is worth noting, that on a 
phylum level, the composition of human gut microbiota is also similar to that of other 
mammals, but most bacterial families and genera are distinct (Dethlefsen L. et al., 2007). 
These facts suggest co-evolution of humans with their microbial gut residents. In line with 
this, Sekelja et al. (2010) have discovered two core phylogroups shared among 210 
individuals with various ethnic background and diet habits. 
Recently, the occurrence of immune-mediated disorders such as inflammatory bowel disease 
(IBD), asthma, and type I diabetes, has increased so rapidly in the Western world that solely 
the genetic basis of these diseases is unlikely to be the only reason (Blaser M., Falkow S., 
2009). Instead, the altered composition of intestinal microbiota, and thus host-microbiota 
interactions, due to various antimicrobial strategies might also be an explanation of this 
phenomenon. Several correlations between the microbial composition and the disease state 
have been reported so far, however it is not certain whether the reported dysbiosis is the cause 
or, conversely, the consequence of a disease (Round J., Mazmanian S., 2009). Certainly, in 
many aspects of our physiology and well-being we are truly dependant on these intestinal 
residents and therefore nowadays it is becoming more and more common to regard intestine - 
microbiota relationships as symbiotic, and not commensal as thought previously. In various 
studies of gnotobiotic animals, it has been demonstrated that germ-free animals show defects 
in the development and maturation of a range of gut-associated lymphoid tissues, which, 
however, could be restored shortly after introduction of gut bacteria (Shanahan F., 2009). For 
example, germ-free mice, infected with enteric parasite Encephalitozoon cuniculi, and treated 
with DNA isolated from intestinal microbiota, have shown upregulation of pro-inflammatory 
TH17 and TH1 cells response which resulted in a better resistance to the parasite (Round J., 
Mazmanian S., 2009). At the same time, enteric bacteria can not only stimulate, but also 
suppress the immune response – for instance Bacteroides fragilis produces polysaccharide A 
(PSA), a molecule which stimulates the production of anti-inflammatory Treg cells (Shanahan 
F., 2009). Intestinal microbiota has also been shown to produce short chain fatty acids 
(SCFA), conjugated linoleic acid (CLA), essential amino acids, vitamins B and K, all 
contributing to the well-being of a host (Marques T. et al., 2010).  
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1.2 Bifidobacterium species in the human gut  
1.2.1 Description of Bifidobacterium 
Bifidobacteria are Gram-positive branched rod-shaped bacteria belonging to the phylum of 
Actinobacteria. They are non-spore forming non-motile anaerobic microorganisms producing 
acid but not gas from various carbohydrates (Tannock G., 2010). The species of this genus 
was first discovered in 1899 by Tissier and was referred to as Bacillus bifidus, but later was 
classified as Bifidobacterium bifidum. For their resemblance with lactobacilli in many 
morphological and physiological aspects, at first they were collectively referred to as 
Lactobacillus bifidus. In 1960s, the ‘bifid shunt’, a specific Bifidobacterium hexose 
fermentation pathway with help of a fructose-6-phosphate phosphoketolase (F6PK), was 
discovered (de Vries W., Stouthamer A., 1967). Only after this discovery, the genus was 
separated from lactobacilli. Thirty-two species of Bifidobacterium have been discovered so 
far, including B. tsurumiense and B. mongoliense, identified in 2008 and 2009, respectively. 
The species were isolated from human intestines, oral cavities, blood, food, animal and insect 
intestines, and sewage (Ventura M. et al., 2010a). As assessed by comparative genomic 
analysis of conserved genes including 16S rRNA sequences, the genus comprises 6 groups 
with the B. asteroides group being the deepest branch. Out of 32 species, complete genomic 
sequences of 9 bifidobacterial species and partially assembled genomes of 17 species have 
been generated to date. In general, bifidobacterial genomes show strong synteny both between 
and within the species. However, some species, e.g. B. longum, possess high numbers of 
unique genes (Ventura M. et al., 2010b).  
Bifidobacteria are prototrophic organisms capable of synthesis of at least 19 amino acids, 
pyrimidine and purine nucleotides, nicotinate, thiamine and folate. So far, 696 orthologous 
proteins forming the core genome of Bifidobacterium species have been identified on the 2.0 
– 2.8 Mb long chromosome with a high G+C content  (Ventura M. et al., 2010b). All together, 
about 10 % of bifidobacterial proteome comprises enzymes involved in carbohydrate 
transport and metabolism, which is almost 30 % higher than that of other enteric bacteria such 
as E. coli, Enterococcus faecium and Lactobacillus spp. Bifidobacterium possess a rich set of 
internal glycosyl hydrolases (GH) which are often linked and clustered with genes encoding 
ATP-binding cassette (ABC) transporters, permeases and proton symporters used for the 
binding and transporting of complex sugars into the cell. It has been recently estimated that 
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carbohydrate transport comprises about 5 % of the bifidobacterial genome and most of the 
genes involved in sugar metabolism have been duplicated (Ventura M. et al., 2009). The level 
of horizontal gene transfer (HGT), which is responsible for the bacterial adaptation and 
competitiveness in their ecological niche, varies greatly among bifidobacteria. For example, 
less than 5 % and 1 % of chromosome sequences of B. longum longum NCC2705 and B. 
dentium Bd1 respectively have been acquired by HGT (Ventura M. et al., 2010b). 
Bifidobacterial GHs are predicted to hydrolyze starch, fructooligosaccharides (FOS), 
galactooligosaccharides (GOS), arabinogalactans, arabinoxylans and human milk 
oligosaccharides (HMO). The latter is especially evident among B. longum infantis which is 
the only Bifidobacterium species growing robustly on purified HMOs. LoCascio et al. (2010) 
have recently shown that B. longum infantis possesses conserved HMO utilization gene 
regions as opposed to the closest related species, B. longum longum.  
Nine Bifidobacterium species are commonly associated with the human GIT – B. 
adolescentis, B. breve, B. longum subsp. longum and B. longum subsp. infantis, B. 
pseudolongum, B. bifidum, B. pseudocatenulanum, B. dentium, B. animalis subsp. lactis. The 
recent study of stool and intestinal biopsy samples have revealed that the latter two species are 
mostly found in stool, but not mucosal samples, suggesting that these represent allochthonous, 
i.e. transient, microbiota and are not mucosa-adherent species (Turroni F. et al., 2009). B. 
dentium is often found in oral cavities and is believed to be associated with dental caries, 
whereas B. animalis lactis has a dairy origin and is normally associated with food (Ventura 
M. et al., 2010b). It is generally believed that Bifidobacterium composes around 2 % of the 
total intestinal microbiota in adults, whereas at early days of life this genus makes up the 
majority of intestinal bacteria and reaches up to 90 % (Tannock G., 2010). However, some 
scientists claim the relative numbers in adults are higher, and that bifidobacteria constitute up 
to 15 % of the total gut microbiota (Menard O. et al., 2008), whereas others suggest much 
lower abundances of these species among infants (Palmer C. et al., 2007). Some 
bifidobacterial strains, e.g. B. pseudolongum, are exclusively associated with adult gut 
microbiota, and some, especially B. longum infantis, are typically isolated from infants. At the 
same time, other bifidobacterial strains, such as B. adolescentis, B. longum longum, B. breve 
and B. pseudocatenulanum, seem to be present in our guts irrespective of the age (Ventura M. 
et al., 2010a).  
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1.2.2 Role of Bifidobacterium in the human infant gut 
High abundance of Bifidobacterium species in infants is believed to have a promoting effect 
on sustaining health of an individual as well as on the development and maturation of the 
immune system. Bifidobacteria can stimulate the immune system with a host-health 
dependent pattern of stimulation – they are capable of both strengthening immune responses 
in healthy individuals and down-regulating pro-inflammatory responses in pathological 
conditions such as inflammatory bowel disease (Rossi M., Amaretti A., 2010). 
Bifidobacterium strains suppress production of TH2 cytokine and IgE, an abnormal response 
of which is regarded to be characteristic of an allergic reaction (Miyauchi E. et al., 2010). 
However, the immunomodulatory ability of Bifidobacterium species appears to be strain 
dependent – B. bifidum, B. dentium and four B. longum strains induce TH1 and/or TH2 
cytokines, whereas other have a low (B. breve, three strains) or no effect (B. adolescentis) on 
the immunity of gnotobiotic mice (Menard O. et al., 2008). Even though B. adolescentis 
seemed to have no effect on the immune system in the latter study, this species is often found 
in higher counts among allergic children (Ouwehand A. et al, 2001; Stsepetova J. et al., 2007). 
B. longum infantis has been shown to inhibit production of pro-inflammatory IL-17 by 
induction of anti-inflammatory IL-10 in splenocyte and colon cultures  (Miyauchi E. et al., 
2010). In the other study, oral administration of B. lactis Bd12 increased levels of faecal IgA 
in preterm infants 44 % compared to placebo group (Mohan R. et al., 2008). In the same 
study, levels of calprotectin, a protein elevated concentrations of which in preterm infants is 
associated with higher risk of necrotizing enterocolitis, was found lower in a probiotic group. 
By producing lactic and acetic acids in even larger amounts than lactobacilli and lactococci, 
bifidobacteria lower the pH in the colon and thus help to prevent colonization of the gut by 
pathogens. For example, it has been shown that B. longum infantis, isolated from stool 
samples of infants resistant to diarrheal infections, inhibited growth of C. perfigens and E. coli 
(Fliss I. et al., 2010). At the same time, the antimicrobial effect of Bifidobacterium species is 
likely to be caused by production of organic acids rather than by solely lowering pH. When 
lactic and acetic acid were used for lowering pH, the growth inhibition of E. coli and S. 
typhimurium was higher than with hydrochloric acid, indicating that there are other 
mechanisms involved (Makras L., de Vuyst L., 2006). Another antimicrobial ability of 
bifidobacteria is connected to the production of antimicrobial peptides: bacteriocins. The 
species of this genus are generally believed to produce true bacteriocins and bacteriocin-like 
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inhibitory substances (Fliss I. et al., 2010). There are many reports on substances either 
inhibiting some pathogens or preventing their adhesion to epithelial cells, but to date, only 
one bacteriocin, namely bifidocin, has been isolated and characterized (Yildirim Z., Johnson 
M., 1998). 
The ability to adhere to intestinal cells is another important factor for the ability to persist in 
the colon and to compete with enteric pathogens. Bifidobacteria have proven themselves to be 
very effective in inhibiting the adhesion of number of enteric pathogens to Caco-2 and HT-29 
adenocarcinoma-based cell lines in numerous studies (Fliss I. et al., 2010).  Four strains of B. 
bifidum have been shown to be capable of displacing such pathogens as E. coli, C. difficile, 
Ent. sakazakii, S. typhimurium and L. monocytogenes attached to the mucosal epithelium. The 
displacement levels ranged from 15 % to 70 % depending on the strain and the pathogen 
tested (Guiemonde M. et al., 2007). Though the mechanism remains unknown, the authors 
hypothesize that various factors, some of which could be thermolabile in nature, are involved, 
as both treatments with proteinase K, lipase, metaperiodate and thermotreatment have reduced 
the adhesion of tested strains.  
Mammals lack the ability to synthesize certain vitamins, and therefore these have to be 
obtained from other sources like diet or gut microbiota. Bifidobacterium species are generally 
believed to produce vitamins of the group B including folate, cobalamin, pyridoxine, 
riboflavin and thiamin. In 2007, 76 strains of 15 Bifidobacterium species of human and 
animal origin were tested for their ability to produce folate, – water-soluble vitamin B9. In 
total, 17 strains belonging to 9 species were capable of folate production, with two strains of 
B. adolescentis and one strain of B. pseudocatenulanum being the top-three producers 
(Pompei A. et al., 2007). In the other study, 24 strains belonging to species of B. bifidum, B. 
breve, B. longum longum, B. longum infantis and B. adolescentis were tested for their ability 
to produce B vitamins (Deguchi Y. et al., 1985). All tested strains were able to produce 
pyridoxine (vitamin B6) and small amounts of cobalamin (vitamin B12), which is very 
important in early days of life as it is responsible for the normal growth and development of 
the nervous system (Marques T. et al., 2010). Production of thiamin (vitamin B1) and 
nicotinic acid (vitamin B3) seems to be strain-dependant as all tested B. bifidum, B. longum 
infantis, and some of B. breve strains were high producers, while B. adolescentis and some 
strains of B. longum longum and B. breve lacked this ability  (Deguchi Y. et al., 1985). 
Despite this ability, however, it remains unclear whether the amount of vitamins produced by 
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bifidobacteria makes any contribution to the vitamin status of the host (Rossi M., Amaretti A., 
2010).  
Certain Bifidobacterium strains, especially B. breve and B. dentium, are also capable of 
transformation of linoleic acid into bioactive conjugated linoleic acid (CLA) – the component 
believed to have anti-carcinogenic, anti-diabetes, anti-obesity and anti-allergy functions. 
Same as with vitamins, there is little information available on whether or not bifidobacteria 
can make a contribution to the levels of CLA in the host  (Rossi M., Amaretti A., 2010). 
However, some scientists ascribe the change in the fatty acid composition of the liver and 
adipose tissue to the consumption of certain bifidobacteria strains (Shanahan F., 2009). 
1.2.3 Bifidobacterium spp. identification and quantification 
Culturing is the conventional method of Bifidobacterium species identification and 
enumeration and many selective media have been developed for that purpose (Ferraris L. et 
al., 2010). However, the recovery of different bifidobacterial species varies and every medium 
may favor some, while inhibit the growth of other, Bifidobacterium species (Roy D., 2001). 
Therefore molecular methods are widely used for the identification and quantification 
purposes. Quantitative real time PCR (qRT-PCR) targeting 16S rRNA gene is an example of a 
molecular approach, which is commonly used for Bifidobacterium quantification (Haarman 
M., Knol J., 2005). However, the number of 16S rRNA gene copies per bifidobacterial 
chromosome may vary from 1 to 5 depending on the strain (Candela M. et al., 2004), which 
may lead to over- or underestimation of some species. Furthermore, 16S rRNA provides 
relative low resolution for strain discrimination due to the conserved nature of this gene 
(Ventura M. et al., 2006). 
Multilocus sequence typing (MLST) is a molecular approach of species delineation by 
comparing the sequences of several housekeeping genes (Maiden M. et al., 1998). MLST 
approach is widely used for various bacteria and the databases with sequence profiles are 
publically available (Jolley K., 2011). Deletoile et al. (2010) used seven genes for MLST of 
119 strains belonging to four Bifidobacterium species. This resulted in identification of 104 
sequence types (ST) based on a combination of allelles, which demonstrates high 
discriminatory power of the method.  
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The gene encoding caseinolytic protease C (clpC) is one of the seven genes used for MLST of 
Bifidobacterium species and it has 34 identified alleles. Caseinolytic protease C (ClpC) 
belongs to a heat stress resistance proteins of the Clp ATPase family, and  is believed to be 
involved in recognition of proteins for the degradation by ClpP caseinolytic peptidase 
(Sanchez B. et al., 2010). The clpC gene was first proposed as a molecular marker for 
Bifidobacterium delineation in 2005 (Ventura M. et al., 2005). Among 32 type strains of 
Bifidobacterium species tested, clpC gene was successfully amplified in all strains apart from 
B.minimum LMG 11592
T
, though in the latter species clpC was detected by hybridization
 
(Ventura M. et al., 2006). The clpC gene allows better phylogenetic resolution of 
bifidobacterial taxa compared to 16S rRNA – mean sequence similarities of 16S rRNA 
sequences are higher and mean pairwise distances are lower than those of clpC sequences. For 
example, 16S rRNA sequences of B. animalis animalis and B. animalis lactis, and of B. 
longum longum, B. longum infantis and B. longum suis have more than 99 % sequence 
similarity making it impossible to discriminate them, whereas delineation of these species by 
means of clpC sequences is supported by high bootstrap values (Ventura M. et al., 2006). At 
the same time, in Bifidobacterium, the clpC gene is a single-copy gene (Ventura M. et al., 
2005), making it more suitable for the relative quantification of Bifidobacterium species as 
opposed to the 16S rRNA gene. 
 In addition to its conservation, this gene is also unlikely to be affected by HGT (Ventura M. 
et al., 2006). However, in the other study, where 119 strains belonging to four 
Bifidobacterium species were tested, the clpC gene of B. longum infantis CIP6467 was 
identical to that of B. bifidum strains and the clpC gene of B. bifidum B526 – to B. longum 
longum isolates, indicating the possibility of HGT (Deletoile A. et al., 2010).  
1.3 Application of mixed sequences to analyze bacterial 
diversity 
Trosvik et al. (2007) used mixed sequences for the quantitative analysis of the microbial 
population. They showed that multivariate regression analysis of mixed sequences allows 
direct quantification of genetically coherent units (GCUs) in the mixture of bacterial species. 
However, with the statistical approach they used, the prior knowledge of the composition, i.e. 
what GCUs are present in the system, was required.  
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Multivariate curve resolution analysis with alternating least squares (MCR-ALS) is a 
statistical tool which allows the recovery of pure components from various mixtures when no 
prior knowledge about the nature and composition of these mixtures is available (Tauler R. et 
al., 1995). It is extensively used for resolution of spectral, pH, time and elution profiles of 
diverse environmental samples (Tauler R. et al., 2010) and recently it has been proposed as a 
promising tool for the analysis of image data from DNA microarrays (Jaumot J. et al., 2006). 
However, to our knowledge, apart from the study of Sekelja M., MCR-ALS has never been 
applied for the analysis of mixed DNA sequence spectra (Zimonja M. et al., 2008). The 
approach was tested on two datasets of predefined mixtures of 16S rRNA amplicons from 
three (Bacteroides, E. coli and Faecalibacterium) and seven (Bacteroides, E. coli, 
Faecalibacterium, Clostridium, Eubacterium, Lactobacillus and Ruminococcus) bacteria 
respectively. All in all, for both datasets tested, MCR-ALS proved itself to be a suitable tool 
for resolution, identification and relative quantification of mixed 16S rRNA amplicons 
(Zimonja M. et al., 2008).  
Mathematically, the MCR-ALS method presents the initial experimental matrix of spectral 
data D (m×n) as the combination of concentration matrix C (m×i) and matrix of pure 
components S (i×n), and a residual term E (m×n): 
                                                            D = CS + E                 (Eq. 1.1) 
Prior to the MCR-ALS analysis, only the initial matrix D is known. However, the initial 
number of components (initial estimates i) should also be defined (Tauler R. et al., 1995). To 
do so, progressive or iterative local rank methods like Principal Component Analysis (PCA) 
or Evolving Factor Analysis (EFA) are used. PCA transforms the initial data into another 
coordinate system and defines the number of significant components in the system depending 
on how much of the whole system’s variance the component explains (Smith L., 2002). EFA 
on the other hand, repeatedly applies PCA to sections of the dataset starting from the first two 
samples and subsequently adding the next one every run of the PCA. EFA can be performed 
in two ways – forward or backward analysis depending on the direction of moving the 
window, i.e. sub-datasets of mixtures (Garrido M. et al., 2008). 
A simplified explanation of the MCR-ALS analysis is presented in Figure 1.1. Imagine the 
hypothetical dataset of mixed DNA spectra consists of two sequences. PCA and EFA 
predicted 3 components to be present in the given dataset. Performing MCR-ALS with a 
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number of components to be resolved set to 3, will result in two separate matrices, one of 
which will contain the information on the spectral data of these three components (S), and the 
other – the concentration profiles of each of the resolved components in every mixed DNA 
sample (C). 
 
Figure 1.1 Simplified scheme of MCR analysis. The number of 
components to resolve is defined from PCA/EFA analysis. As a result, 
pure spectra and their relative amount in each of mixed spectra are 
defined. 
1.4 Aims of the project  
Despite the growing interest in Bifidobacterium spp., little is known about the development of 
these bacteria in infant guts and about the correlation of its composition in the infant gut to 
various environmental factors. The aim of this project was therefore to determine the factors 
which correlate to the development of Bifidobacterium species in infants. The specific goals 
to reach the overall aim were: 
- To identify the dominant Bifidobacterium species and their composition at different 
ages relative to both the total bacterial load and to Bifidobacterium spp.; 
- To identify B. longum group species composition at different ages; 
- To reveal the interactions between Bifidobacterium species and other bacterial groups; 
- To determine mother- and infant- related factors correlating to the composition of 
Bifidobacterium species; 
- To determine the difference in the composition and development of Bifidobacterium 
species in healthy infants and those who suffered from allergy and/or eczema.   
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To reach these goals we used a data generation approach involving MCR-ALS analysis of 
mixed Bifidobacterium clpC gene sequences amplified from stool samples of mothers and 
their infants. Data analyses were based on non-parametric tests of statistical significance, 
network analysis and presence/absence test. 
1.5 Frame of the project 
This project was conducted using stool specimens received from the IMPACT study. The 
Prevention of Allergy among Children in Trondheim (PACT), a controlled non-randomized 
intervention study of pregnant women and their children up to two years of age, was started in 
2000. (Størro O. et al., 2010). At the same time, a randomized nested-cohort study 
(Immunology and Microbiology in Prevention of Allergy among Children in Trondheim – 
IMPACT) of 720 pregnant women and their offsprings, recruited from PACT control cohort, 
was also initiated. The aim of the IMPACT study was to analyze the development of intestinal 
microbiota in infants during the first years of their life depending on various environmental 
factors, as well as its influence on the maturation of immune system and establishment of 
asthma (Øyen T. et al., 2006).  
Stool samples from the IMPACT study were received from the Norwegian University of 
Science and Technology (NTNU) and DNA isolation was performed by de Muinck (de 
Muinck E. et al., 2011). PCR amplification of clpC gene was completed as a part of a 
Bachelor’s degree project (Glazowska S, Czebreszuk U, 2010). Information on total bacterial 
composition was received from MCR-ALS based analysis of 16S rRNA amplicons (Appendix 
A). The MATLAB
®
 code for pre-analytical alignment and correction of mixed spectra was 
designed by Sekelja M. (Zimonja M. et al., 2008).  
In this thesis, mixed clpC gene amplicons of the DNA isolated from IMPACT stool samples 
were sequenced and then analyzed using a novel MCR-ALS approach. As a result, the 
dominant Bifidobacterium species were identified. To verify the dominant species, clpC gene 
amplicons of selected samples were cloned into E. coli, PCR amplified and sequenced. The 
percentage of Bifidobacterium species, relative to both total Bifidobacterium and total 
bacterial load (identified with the same approach on 16S rRNA gene amplicons; Appendix A) 
was compared to various clinical and environmental factors to check for the correlations. 
Local Similarity Analysis was performed to reveal the correlations between the abundances of 
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bifidobacterial species. The B. longum group was resolved by sequencing with a specific B. 
longum-group primer. A growth competition test was performed on B. longum longum 
DSM20219 and B. longum infantis DSM20088, grown on semi-synthetic media with a single 
carbon source. Isolation of B. longum longum and B. longum infantis from stool samples, 
where they were predicted to be abundant, was attempted. A flow diagram showing the 
processes performed in this project is presented in Figure 1.2.  
 
Figure 1.2 Flow diagram of the study. Boxes and ellipses represent processes and data 
or materials obtained from them respectively. Dark background shows work done prior to 
the start of the project. 
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2 Materials and methods 
2.1 Clinical material and information 
Stool samples from 110 children and their mothers, as well as the information on their diet, 
allergy status and diseases, were received from the IMPACT study (Øyen T. et al., 2006). 
Mothers’ stool samples were collected at two points during pregnancy (early period – from 
first to the middle of the second trimester; late period – third trimester) and infant stool 
samples  – at age 2-4 and 10 days; 4 months; 1 year and 2 years after birth. The samples (2 g) 
were diluted in 10 ml of sterile Cary Blair medium (BD Diagnostics, USA) and frozen at -20 
°C no later than 2 hours after the collection. Within a month, samples were transferred and 
stored at -80 °C (Øyen T. et al., 2006). 
Information on the lifestyles of pregnant women and their children was gathered through a 
questionnaire filled out during pregnancy, at 6 weeks, 1 year and 2 years after birth (Størro O. 
et al., 2010). Information on the mothers’ style of living during pregnancy included pets at 
home; smoking; whether the mother experienced having a cold or fungal infection; whether 
mothers ate fatty fish and/or took fish oil; and whether they ate vegetables more than once 
and/or more than four times a week. Information on the infants consisted of data on their 
lifestyle during the first year of life (pets at home; smoking parents; whether they were given 
multivitamins during first 6 weeks and 1 year of life; and whether he/she was breast-fed 
throughout the first year of life), his/her allergy status (total specific IgE levels in blood serum 
more than 0.1; 0.35 and 0.7 kU/ml) and eczema status by the age of 2 years. The level of 
serum IgE was measured for such allergens as mites, mold, cat and dog dander, birch, timothy 
(grass) and mugwort pollens, cow’s milk, hen’s egg white, codfish, hazelnut and peanut 
(Størro et al., 2011). Eczema was assessed using both the UK Working Party (UKWP) 
diagnostic criteria for atopic dermatitis and mothers’ answers to a questionnaire (whether the 
baby was experiencing eczema symptoms).  
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2.2 DNA isolation 
2.2.1 DNA isolation from freeze-dried strains 
Pure strains of B. longum longum (DSM20219), B. longum infantis (DSM20088), B. breve 
(DSM20213) and B. adolescentis (DSM20083) were obtained from the German Collection of 
Microorganisms and Cell Cultures (DSMZ, Germany). After the glass ampule with freeze-
dried culture was opened according to recommendations from the manufacturer, the pellet 
was resuspended in 500 µl of ‘solution A’ [25 mM Tris-HCl pH 8.0, 10 mM EDTA pH 8.0; 
0.22 µm sterile-filtered] for 30 min. The sample was then transferred to a tube with 0.25 g 
acid-washed glass-beads ≤ 106 µm (Sigma-Aldrich, Germany), boiled for 5 minutes and 
cooled on ice before cell homogenization. Cells were homogenized in MagNA Lyser (Roche, 
Switzerland) at 6500 rpm for 25 seconds 4 times (to prevent DNA degradation due to 
overheating, tubes were cooled down for 1 minute between each step). Proteinase K (25 µl; 
100 mg/ml) was added to 180 µl of lysate and incubated at 56 °C for 30 min. After 
incubation, ethanol (96 %, 200 µl) was added to the tube and DNA isolation was proceeded as 
described in ‘Purification of Total DNA from Animal Tissues (Spin-Column Protocol)’ for 
Qiagen Stool kit starting from step 4 (Qiagen, USA).  
2.2.2 DNA isolation from bacterial cultures 
Bacterial cultures were aliquoted into Eppendorf tubes (1 ml), centrifuged at 13 000 rpm 
(Biofuge 13) for 5 min at RT and the cell pellet was resuspended in TE Buffer [10 mM Tris-
HCl pH 8.0; 1mM EDTA] (100 µl). Then lysozyme (10 µl; 10 mg/ml) was added and the 
tubes were incubated for 30 min at RT. After the lysis, binding buffer [500 µl; 7.5 M 
Guanidinium thiocyanate; 150 mM Tris-HCl pH 6.8; 7.5 mM EDTA] and 10 µl of 
SiMAG/MP-DNA Magnetic Beads (Chemicell GmbH, Germany) were added into the tubes 
which subsequently were incubated at RT for 5 min. The tube was then placed on the 
magnetic separator for 30 sec and the bead/DNA pellet was retrieved and  treated with 
washing solution I [1 ml; 60 % (w/v) Guanidinium hydrochloride; 1 % Triton X100; 10 % TE 
Buffer pH 8.0], 70 % ethanol (1 ml) and ddH2O (1 ml). After each washing step the tube was 
placed into the magnetic separator and the pellet was collected. Then elution buffer [100 µl; 
10 mM Tris-HCl pH 8.0; 1 mM EDTA] was added to the tubes and samples were incubated in 
a thermomixer (Eppendorf, Germany) for 10 min at 60 C with mixing (1000 rpm). Finally, 
the beads were collected and the solution with eluted DNA was transferred to a new tube. The 
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concentration of isolated DNA was determined using a NanoDrop spectrophotometer 
(Thermo Scientific, USA). 
2.2.3 DNA isolation from stool samples 
Stool samples (1 ml) were first diluted in 1 ml of Solution 1 [50 mM glucose; 25 mM Tris-
HCl pH 8.0; 10 mM EDTA pH 8.0]. The resulting suspension was then diluted 1:4 in 4 M 
guanidinium thiocyanate. The sample (500 µl) was transferred to a sterile FastPrep®-tube 
(Qbiogene Inc, USA) with 250 mg acid-washed glass beads (≤ 106 µm; Sigma-Aldrich, 
Germany) and homogenized in FastPrep® Instrument (Qbiogene Inc, USA) for 40 sec. Then 
170 µl of the sample together with 10 µl of Silica particles (Merck, Germany) were 
transferred to 96-wells Greiner U-plate (Greiner Bio-One, Germany) which was then placed 
in a Biomeks 2000 Workstation (Beckman Coulter, USA). After addition of Sarkosyl (1 %), 
the plate was incubated at 65 °C for 10 min, followed by 10 min at RT. Then the supernatant 
was discarded and a bead pellet was washed twice with 50 % ethanol. The beads were 
suspended in Buffer C [100 µl; 1 mM EDTA pH 8.0, 10 mM Tris–HCl pH 8.0], incubated at 
65 °C for 30 min and the solution with eluted DNA was collected.  
2.3 PCR amplification  
One microliter sample DNA was mixed with a PCR-master mix [1x Dynazyme II HotStart 
Buffer, 0.08 mM dNTPs, 0.2 µM forward primer, 0.2 µM reverse primer, 0.04 U/µl 
Dynazyme II HotStart enzyme, in DNase/RNase free water] to a final volume of 25 µl. 
Concentrations are given according to final concentrations in the PCR mix with added DNA. 
For each PCR reaction, 30 cycles were used. Initial denaturation was performed at 95 °C for 
10 min. Denaturation times at 95 °C and annealing times were set for 30 sec. For the 
annealing temperature, elongation time and primers used see Table 2.1. Polymerization was 
finished at 72 ºC for 7 min. Amplicons were checked with 1.5 % Agarose gel (100 V; 30 
min). All used oligonucleotides were obtained from Invitrogen (USA). 
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Table 2.1 Primers used for DNA amplification and sequencing. OligoCalc online calculator (Kibbe 
W., 2007) was used for melting temperature calculation 
Primer 
name 
Sequence of the primer in 5’3’ 
direction 
Direction Tm, °C 
Annealing 
temp, °C 
Elongation 
time, 
min:sec 
clpC-F GAGTACCGCAAGTACATCGAG forward 54.4 
60 1:00 
clpC-R CATCCTCATCGTCGAACAGGAAC reverse 57.1 
clpC-L AGAAGCTGGAAGCCGAT forward 52.1 60 – 
HU CGCCAGGGTTTTCCCAGTCACGACG forward 64.2 
65 2:00 
HR GCTTCCGGCTCGTATGTTGTGTGG reverse 60.8 
2.4 DNA sequencing 
To degrade excess single-stranded primers, PCR-products (1 µl) were treated with 
Exonuclease I (New England Biolabs, UK) [BigDye Sequencing buffer 5X; ExoI 0.4 U/µl; 
DNase/RNase free water to 5 µl] at 37 °C for 60 min. Enzyme was inactivated at 85 °C for 15 
min. ExoI-treated PCR products (1 µl) were sequenced in forward direction [BD Sequencing 
Buffer 5X; 0.32 µM sequencing primer 1 µl; BigDye Terminator v1.1 1 µl; DNase/RNase 
free water to 10 µl]. DNA was sequenced for 25 cycles at 96 °C for 15 sec, followed by 60 °C 
for 4 min. Sequencing reaction was then cleaned up using BigDye XTerminator (ABI, USA) 
following manufacturer’s protocol. Capillary electrophoresis was performed on 3130xl 
Genetic Analyzer (ABI, USA) with 7 sec injection time. Sequencing was performed in two 
sets: first, 1 µl of ExoI-treated PCR product was used. After examination, those samples 
which had low or no signal were re-sequenced with a double amount of PCR product used. In 
case of still absent/low signal, the samples were removed from the analysis. 
The clpC-F primer was used to sequence all Bifidobacterium species present in the samples; 
whereas for B. longum longum/B. longum infantis separation, clpC-L, a primer, specific for B. 
longum group, was designed (Chapter 3.2.2). 
2.5 Cloning 
To confirm whether Bifidobacterium spp., predicted by MCR-ALS, were truly present in the 
dataset, clpC-amplicons of DNA isolated from 14 stool samples were cloned into pCR
®
 2.1-
TOPO
®
 vector and then used to transform chemically competent TOP10 E.coli cells using 
TOPO TA Cloning
®
 kit (Invitrogen, USA). Due to the fact that for successful cloning, PCR 
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products should be not more than 1 day old, and due to lack of DNA, the cloning was 
performed on PCR products of 1/10 diluted PCR products. Amplification was performed 
according to the protocol described above (Chapter 2.3) using 10 cycles.  
Transformed E.coli cells were then grown on LB medium agar plates with addition of 
kanamycin (50 mg/l; 0.2 µm filter-sterilized) at 37 °C for 48 – 72 hours. Colony PCR (10 
colonies per sample) with HU/HR primers (Table 2.1) targeting the vector, was then 
performed on transformants. The sequencing of PCR products was done according to the 
protocol described above using the clpC-F primer (Chapter 2.4). 
2.6 Bacterial isolation and cultivation – competition 
experiment 
2.6.1 Bacterial isolation 
Four stool samples which were predicted to be rich in the B. longum group (2 in B. longum 
longum and 2 in B. longum infantis) were diluted in saline [0.91 % (w/v) NaCl; 0.2 µm filter-
sterilized] 10, 100 and 1000 fold. Though higher dilution rates are recommended, normally 
experiments are performed on fresh stool samples, whereas in case of this study, stool 
samples were kept at -80 °C for 8 years. Diluted samples were then streaked on plates 
containing Bereens medium [Columbia Agar base (Merck, Germany) 42.5 g/l; glucose 2.5 g/l; 
lactulose 2.5 g/l; cysteine HCl 0.5 g/l; riboflavin 0.01 g/l; propionic acid 5.0 ml/l]. The 
medium was autoclaved at 118 °C for 15 min prior to addition of propionic acid and 
riboflavin. Plates were then placed in a 3.5 l Anaerobic jar (Oxoid, France) with GENbox 
anaerobic generator (BioMerieux, France) and kept at 37 °C for 72 hours. Anaerobic 
conditions were verified using a Microbiology Anaerotest indicator (Merck, Germany). The 
experiment was repeated using Wilkins-Chalgren for Bifidobacterium Mupirocin (Ferraris L. 
et al., 2010) [Wilkins-Chalgren agar (Merck, Germany) 43 g/l; Tween 80 0.5 %; glucose 10 
g/l; cysteine-HCl 0.05 % (w/v); mupirocin 50 mg/l]. Prior to inoculation, plates were kept 
anaerobically at RT for 24 hours.  
After 72 hours incubation, plates were examined and colonies of interest were inoculated into 
liquid MRS medium (Merck, Germany) supplemented with 0.1 g/l cysteine-HCl and grown 
anaerobically at 37 °C for 1 day. DNA isolation, PCR and sequencing reactions were 
performed as described previously (Chapters 2.2.2; 2.3 and 2.4 respectively).  
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2.6.2 Competition experiment 
Pure cultures of B. longum longum and B. longum infantis were obtained from the German 
Collection of Microorganisms and Cell Cultures (DSMZ, Germany). Ampules containing a 
freeze-dried culture of B. longum longum (DSM 20219) and B. longum infantis (DSM 20088) 
were opened, 50 µl of Anaerobe Basal broth (Oxoid, France) was added to the inner tube and 
cells were left to rehydrate for 30 min. After the pellet was gently resuspended, cells were 
added to 5 ml of Anaerobe Basal broth (Oxoid, France), and incubated for 2 days at 37 °C. 
Pure cultures were mixed in 1:1 proportion, and 100 µl of the resulting mixture were added to 
1 ml of a semi-synthetic medium (Barrangou R., 2003) with addition of (a) lactose (Sigma 
Aldrich, Germany) or (b) lacto-N-biose (Dextra Laboratories, UK) as a single C-source (1.5 
%). Medium without a C-source and Anaerobe Basal broth medium were used as controls. 
Prior to mixing bacteria, pure cultures were diluted in Anaerobe Basal broth medium to reach 
equal OD600. DNA isolation, PCR and sequencing reactions were performed both prior to, and 
after, incubation at 37 °C for 1 day with a semi-synthetic medium.  
2.7 Bioinformatics and statistics 
All the analyses of sequence spectra were performed using MATLAB
®
 R2010a software (The 
MathWorks Inc., Natick MA, USA), Statistical and Bioinformatics toolboxes for MATLAB
®
. 
For EFA, PCA and MCR analyses, PLS Toolbox v5.8 for MATLAB
®
 (Eigenvector Research 
Inc., USA) was used. 
Following sequences were used as references: clpC allelic profiles downloaded from the 
Bifidobacterium MLST Database (Brisse S. et al, 2009); clpC gene of B. adolescentis 
(DQ238016); B. breve (AB437352); B. dentium (AY722387); B. bifidum (DQ206821); B. 
longum longum (AB437353) and B. longum infantis (AY722381). 
2.7.1 Alignment and trimming of sequence spectra  
The original script for aligning and trimming 16S rRNA sequence spectra for further analysis 
using MCR-ALS was written by Monika Sekelja (Zimonja M. et al., 2008). For this project, 
the script was optimized for its use with clpC gene amplicons. All query sequences are 
aligned to a predefined start fragment (20 nucleotides long), trimmed, then aligned to the end 
fragment (17 nucleotides long) and trimmed again (Figure 2.1). Quality of spectra alignment 
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is crucial for the performance of MCR-ALS – any shifts or deviations in peaks would mask 
actual similarity between the data and thus hinder the prediction of the common spectra. To 
correct for retention shift differences and to increase the linearity of the data (Zimonja M. et 
al., 2008), after the alignment the spectra were first preprocessed using correlation optimized 
warping (COW) and then normalized. COW allows aligning the given spectrum towards the 
reference one by moving segments of the spectrum within the defined limit (Tomasi G. et al, 
2004). 
 
Figure 2.1 The scheme of sorting and trimming of sequences. 
Query sequences are screened for the reference ‘start’ and 
‘end’ fragment (each approx. 20 bp long). Those which fail to 
have either of them are removed. All the others are trimmed up 
to the ‘start’ and beyond the ‘end.’ The consensus sequence 
from the multiple alignment of Bifidobacterium clpC alleles was 
used as the reference. 
2.7.2 Resolving spectra 
A multivariate curve resolution analysis (MCR-ALS) with a non-negativity constraint on 
contribution (true least squares solution) was conducted to resolve the spectra. Initially, the 
number of components, i.e. the number of bacterial groups present in the system, was 
determined both by principal component analysis (PCA) and evolving factor analysis (EFA).  
2.7.3 Basecalling spectra 
For decoding resolved pure spectra, we developed a basecaller script for use in the 
MATLAB
®
 environment (Appendix N). Each spectrum is represented by an array containing 
fluorescence intensity measurements of each of four nucleotides at any given time. Plotting 
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these intensities for each of the nucleotides in one figure allows us to visualize the spectrum 
and see the corresponding nucleotide sequence of it. Nucleotides are plotted one after another, 
meaning that firstly all the measurements for one nucleotide are visualized, then they are 
overlaid by the intensities of the second nucleotide and so on, until all four are plotted. The 
basecaller script is based on a similar idea – it has four cycles, during which it takes all the 
intensity measurements for one nucleotide and screens them for peaks (Figure 2.2). Due to the 
fact that background fluorescence intensity can also form noise which has no biological 
meaning, a custom intensity threshold can be set by the user. Each time the peak with an 
intensity higher than a threshold is determined, its coordinate and a part of the initial array 
where it belongs to (i.e., which nucleotide it is), is stored in a separate array. After all 
nucleotides were screened, the resulting array is sorted by peak coordinates, which in turn 
results in nucleotide sequence of the spectra. In case of mixed spectra or bad resolution of 
them, sometimes peaks might be on top of, or too close to each other. Therefore, the 
possibility for setting a threshold for mixed peaks was developed. If the difference between 
the coordinates of two subsequent peaks is lower than the given threshold, the script calls an 
IUPAC nucleotide ambiguity code to re-designate doubly-called peaks.  
       
Figure 2.2 Simplified scheme of a basecaller algorithm. In 
each cycle it takes fluorescence intensity measurements for 
one nucleotide, screens them for peaks and saves the 
coordinate (retention time) of it in a special array. After all the 
nucleotides were screened, the program sorts coordinates, 
which results in a sequence of a given spectrum 
2.7.4 Correlation analysis 
All factors were checked for the cross-correlation to each other using Pearson’s chi-square 
test – an approximate test which uses a contingency table to calculate whether the two 
observations develop independently (Statistics solutions, 2006). 
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The correlation of both the abundance of dominant Bifidobacterium species present in the 
samples at a given time point and of its change over two subsequent time points to various 
factors was calculated using two-sided permutation test with 10
6
 permutation replications. 
The rationale of the permutation test is that, if both groups (e.g., sensitized and non-
sensitized) belong to one distribution, then randomly rearranging the labels to the groups of 
observed values does not affect the absolute difference between means of the ‘new’ 
reassigned groups compared to the original ones (Edgington E., 1995).  
The percentage and development in time were calculated both relative to the Bifidobacterium 
group (MCR predicted percentages) and to the total bacterial load (recalculated from 
percentage of Bifidobacterium group relative to total bacterial load). Data on the total faecal 
microbiota were taken from the previous study of 16S rRNA amplicons of IMPACT samples 
(Appendix A). The significance of the change in the abundance between two subsequent time 
points was calculated with Kruskal-Wallis test, a non-parametric version of one way 
ANOVA. This test makes an assumption that both groups have the same distribution shape 
and scale, except for a difference in medians, rather than that they come from same normal 
distributions as in ANOVA (MATLAB
®
 documentation, 2010).  
In all cases the null hypothesis was rejected at the level of 5 %. 
2.7.5 Presence/absence test 
Individuals, having measurements for their first 4 days of life, as well as for their mothers 
during pregnancy, were included in the analysis. The samples, where the Bifidobacterium 
group was not detected by sequencing, were also added to the dataset. This resulted in a set of 
37 infants and their mothers. Due to the error of MCR prediction, the threshold of 7 % was 
used for binarizing the data – samples with the percentage of Bifidobacterium species lower 
than a threshold were marked as absent, whereas those with the percentage higher or equal to 
7 % were marked as present. The correlation was tested using Fisher’s Exact test calculator 
designed by Øyvind Langsrud (Langsrud Ø., 2004). This independence test determines 
whether associations between two categorical variables and two factors of comparison are 
received by chance by operating on a 2x2 contingency table of these variables and factors and 
calculating a probability value of the relation (Agresti A., 1992). 
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2.7.6 Network calculation 
To analyze the correlation between the given species with regards to the development of other 
species or bacterial groups, a Local Similarity Analysis (LSA) was conducted. This test 
allows identification of spatial and temporal correlations among species, even if those 
correlations are delayed in time and/or are present during a limited period (Xia L. et al., 
2008). This analysis is based on calculating pairwise local similarity scores between time 
series and then checking for the statistical significance of these scores using a permutation 
method (Ruan Q. et al., 2006).  
The resulting network was visualized with Cytoscape software (Cline M. et al., 2007). 
Calculations were performed relative to both Bifidobacterium and total bacterial loads. 
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3 Results 
3.1 Characteristics of raw sequencing data 
Mixed sequences of Bifidobacterium clpC gene from stool samples of mothers and their 
children were obtained in parallel with designing the method. Most of the sequences had 
abnormally shaped fluorescence peaks from the start and up to 30 – 60 bp. Also, the 
resolution of the spectra decreased drastically after 400 bp (Figure 3.1).  
 
Figure 3.1 Example of both (A) abnormally shaped peaks in the beginning of the sequence 
and (B) spectra resolution loss after 400 bp of Bifidobacterium clpC amplicons from stool 
samples of mothers and their children. 
Another common problem we encountered with the sequences obtained from clpC amplicons 
was the formation of high fluorescence intensity signals in several regions of the sequences. 
Mostly, these abnormal peaks were coming from the T-nucleotide (Figure 3.2). 
 
Figure 3.2 Abnormally shaped T-nucleotide high intensity fluorescence 
peaks that may have caused improper correction of spectra alignment  
3.2 Design and validation of mixed clpC sequence analysis 
3.2.1 MCR-ALS resolution of mixed spectra 
Applicability of MCR-ALS analysis for the prediction of Bifidobacterium species present in 
the data set was assessed on predefined mixtures of four species (B. adolescentis, B. breve, B. 
longum longum and B. longum infantis), which are commonly associated with human gut 
microbiota (Tannock, 2010). Mixtures were designed using simplex lattice design resulting in 
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35 mixtures where the PCR product of each strain was present in each of five proportions 
(1:0:0:0; 0.25:0.25:0.25:0.25; 0.75:0.25:0:0; 0.5:0.5:0:0; 0.5:0.25:0.25:0). Initial 
concentrations of PCR products were quantified using Molecular Imaging software (Kodak, 
USA). The experiment was performed in duplicate.  
Profile sequences of 34 known clpC gene alleles were downloaded from the Bifidobacterium 
MLST Database (Brisse S. et al, 2009) and were aligned collectively. Two conserved regions 
which could serve as a start (19-29 bp and 37-59 bp) and two regions which could serve as an 
end (265-288 bp; 580-602 bp) fragments for trimming query spectra were identified (Figure 
3.3).  
 
Figure 3.3 Consensus sequence of 34 clpC allelic profiles progressive multiple 
alignment. Profile sequences were downloaded from the Bifidobacterium MLST 
Database (Brisse S. et al, 2009). Conserved regions are highlighted in blue. A: two 
potential start regions for spectra trimming; B: two potential end regions.  
 Due to high fluorescence regions and loss of resolution (Figure 3.1) it was decided to use 
conserved regions positioned at 37-59 bp and 265-288 bp as start and end fragments 
respectively. Prior to the MCR-ALS resolution, alignments of trimmed spectra were corrected 
using COW.  
To correct for abnormal T-nucleotide peaks (Figure 3.2), we evaluated the possibility of 
spectra resolution without the information on T-nucleotide. We removed fluorescence 
intensity measurements of the T-nucleotide from predefined mixtures, analyzed the spectra 
and compared the results with those, when information on all four nucleotides was available. 
For the spectra identification, T-information was re-substituted on the basecalling stage. 
Classification of pure resolved spectra was performed both by searching the sequence against 
the nucleotide database with BLAST (Table 3.1) and by calculating p-distances between 
resolved components with reference clpC gene sequences of B. adolescentis, B. breve, B. 
longum longum and B. longum infantis (Table 3.2).  
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Table 3.1 Lowest E-value BLAST search hit of MCR-ALS resolved spectra sequences against 
nucleotide database.  
MCR-ALS 
resolved spectrum 
Closest BLAST 
search hit 
GenBank 
accession 
number 
E - value Identity1), % 
Component 1 B. adolescentis DQ238016.1 3*10-107 99 
Component 2 B. breve AB437352.1 3*10-107 99 
Component 3 B. longum AP010889.1 4*10-111 100 
1)  Query coverage – 100 %. 
 
Table 3.2 Pairwise p-distances between MCR-ALS resolved pure spectra from predefined mixtures 
and corresponding reference clpC gene sequences  
Spectra resolved by 
MCR 
Reference spectra
1) 
B. longum 
infantis 
B. longum 
longum 
B. breve  B. adolescentis 
Component 1 0.2330 0.2375 0.2417 0.1029 
Component 2 0.1674 0.1632 0.0879 0.2541 
Component 3 0.0795 0.0837 0.1715 0.2459 
1) Prior to distance calculation, reference sequences were aligned to start and end fragments and 
trimmed 
Correlation coefficient and root mean square error of prediction (RMSEP) were used to 
evaluate the accuracy of MCR-ALS prediction.  
Table 3.3 Correlation coefficients and RMSEP values of MCR-ALS predicted values with regard to 
actual concentration profiles 
 
B. adolescentis B. breve B. longum spp. 
Corr. coef. RMSEP Corr. coef. RMSEP Corr. coef. RMSEP 
General 
prediction 
Duplicate1 0.971 7.677 0.962 7.399 0.985 5.933 
Duplicate2 0.981 5.957 0.970 5.499 0.981 6.506 
T- nucl. 
information 
removed 
Duplicate1 0.972 7.435 0.963 7.166 0.985 5.905 
Duplicate2 0.987 3.813 0.974 5.169 0.967 6.903 
There was 96 % - 98 % correlation between actual and predicted values regardless of whether 
information on all, or just three, nucleotides was present in the dataset (Table 3.3). The 
removal of T-information reduced the error of prediction.  
The possibility of further correction of predicted concentrations using PLS regression was 
tested. This, however, improved the MCR-prediction only to a minor extent by slightly 
decreasing the error (Appendix B). 
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3.2.2 Resolution of the B. longum group 
Due to the fact that most of the nucleotide variation between B. longum longum and B. 
longum infantis starts from 441 bp with regards to the profile consensus (Appendix C), we 
combined the B. longum group for all species identification and resolved it separately. To do 
so, we designed a specific primer which binds closer to a variation site between B. longum 
longum and B. longum infantis. All allelic profiles were collectively aligned with reference 
sequences of the four species used in the mixture design, as well as with those of B. bifidum 
(DQ206821.1), B. dentium (AY722387.1), B. ruminantium (DQ238030.1) and B. animalis 
lactis (AY722379.1). Two positions with a nucleotide specific only for clpC alleles and 
reference sequences of B. longum group were identified in a 200-440 bp region (Table 3.4). 
As long as a variation site between B. longum longum and B. longum infantis starts at 441bp, 
it was decided to use a T-nucleotide positioned at 321 bp as a 3’-end nucleotide in a primer 
for B. longum-group sequencing (Table 2.1).  
Table 3.4. Nucleotide variations in B. longum longum and B. longum infantis profile alleles and 
reference sequences compared to other clpC alleles and reference sequences of B. adolescentis, B. 
breve, B. ruminantium, B. dentium, B. bifidum and B. animalis lactis
1)
 
Position 
number
2) 
Nucleotide in B. 
longum group 
Nucleotide in other alleles 
and reference sequence 
Specificity for the B. longum 
group 
198 T C(G) Yes 
213 C T(G)(C) No 
300 G C(G) No 
321 T G Yes 
328 C G(A)(C) No 
423 C T(C) No 
1) Only those positions for which there was a 100 % likelihood of the given nucleotide in the B. 
longum species and clpC alleles corresponding to the B. longum group species, were compared. 
2) Position number is given according to allelic profiles (603 bp). 
To check for the specificity of the primer, sequencing reactions were performed on PCR 
products from pure B. adolescentis, B. breve, B. longum longum and B. longum infantis, as 
well as on mixtures of PCR products containing equal parts of two of these Bifidobacterium 
species. PCR products of B. longum longum and B. longum infantis were mixed in 50/50 and 
70/30 proportions. There were no sequences obtained from pure B. adolescentis or B. breve 
PCR amplicons, whereas in case of B. longum longum and B. longum infantis mixtures, mixed 
sequences corresponded well with the predefined proportions of each species in the mixture 
(Figure 3.4). 
 35 
 
 
Figure 3.4 Sequencing of predefined mixtures of B. adolescentis; B. 
breve; B. longum longum and B. longum infantis with clpC-L primer. 
100 % likely variations between B. longum longum and B. longum 
infantis are indicated. A, B: 70/30 and 50/50 mixtures of B. longum 
infantis and B. longum longum respectively; C, D: mixtures of the B. 
longum group species with B. adolescentis and B. breve respectively. 
3.3 Identification of dominant species 
3.3.1 Characteristics of clinical material  
In total, DNA isolated from 554 samples was PCR amplified and sequenced. In 113 samples, 
Bifidobacterium was not detected and samples were removed from the analysis. Spectra of 
clpC sequences of the remaining samples were aligned to a common start and end followed by 
trimming. However, some spectra had many abnormal peaks not only caused by T-, but also 
C-nucleotides, or were missing start or end regions. These sequences had to be removed as 
well. Also, after MCR-ALS was performed, those samples that corresponded to the same 
individual at the same age, were removed from the analysis. Overall, out of 110 children and 
their mothers, Bifidobacterium species were identified in stool samples of 83 individuals at 
seven different time points (330 samples in total). At early pregnancy, bifidobacteria were 
identified in 53 % of individuals; at late pregnancy – 41 %; 2-4 days – 41 %; 10 days – 51 %; 
4 months – 71 %; 1 year – 66 % and at 2 years – in 75 % of individuals (Figure 3.5).  
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Figure 3.5 Scheme of number of stool samples (n) on each step of analysis. Loss of 
information is depicted in pale blue rectangles. Spectra of bad quality comprise 
sequences which either had low signal or missed start or end fragment of the 
alignment. Some individuals had two or more stool samples taken at the same age, 
these duplicates were also removed from the final analysis.  
3.3.2 Bifidobacterium group resolution 
PCA and EFA predicted 3 and 6 components in the dataset, respectively. Because iterative 
methods are commonly advised for MCR-ALS analysis (Tauler et al., 1995), we decided to 
perform MCR with 6 components (Appendix D). However, one of the components was poorly 
resolved, resulting in a longer nucleotide sequence spectrum with many mixed peaks which 
were hard to interpret (Figure 3.6). Therefore we repeated the MCR-ALS analysis with five 
components. All five components were well resolved (Appendix E). The basecalled 
components’ spectra were identified by searching the sequence with BLAST against the 
NCBI nucleotide database (Table 3.5). These 5 components explained 57.3 % of the variation 
in bifidobacterial composition of stool samples. 
Table 3.5 Lowest E-value BLAST search hits of MCR-ALS-resolved spectra sequences against the 
NCBI nucleotide database. Five components were used for resolution. Query coverage – 100 %. 
MCR-ALS resolved 
spectrum  
(sequence length) 
Closest BLAST 
search hit 
GenBank 
accession 
number 
E - value Identity, % 
Component 1 (221 bp) B. bifidum CP002220.1 1*10-86 93 
Component 2 (215 bp) B. dentium CP001750.1 3*10-92 95 
Component 3 (219 bp) B. adolescentis DQ238016.1 3*10-107 99 
Component 4 (216 bp) B. breve AB437352.1 4*10-101 97 
Component 5 (221 bp) B. longum AP010889.1 4*10-111 100 
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Figure 3.6 Example of well-resolved (A, MCR with 5 components) and poorly resolved (B, 
MCR with 6 components) component spectrum corresponding to the B. longum group. 
Information on the T nucleotide was removed - blank spaces correspond to T. In the case of 
poorly resolved spectra, two problems arise: peaks are sometimes vague and it is hard to 
decide whether there is information regarding one or two nucleotides (blue arrows), and 
peaks are mixed (yellow arrows). 
To validate identification of dominant species, clpC amplicons of fourteen stool samples were 
selected for cloning. Stool samples were chosen on the basis of the percentage of each 
component, predicted by MCR-ALS. In total, there were 6 samples regarded as pure (the 
abundance of one of the components was more than 80 %), and 8 samples that had a 
combination of two/or more species. Sequencing of cloned inserts confirmed the presence of 
predicted species in corresponding stool samples (Table 3.6). Cloned inserts shared 98 % - 99 
% identity with the corresponding reference sequences deposited in GenBank. In one sample, 
B. animalis was detected.  
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Table 3.6 Number of transformed E.coli colonies that contained clpC gene amplicons from specified 
species.  
ID age 
MCR-predicted composition, % 
Number of colonies where 
the species was detected
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1384 1 y 4.3 3.3 0 4.2 88.2 2 – 3 3 1 – ++/– 
1892 1 y 0 100 0 0 0 – 7 – – – – + 
2650 1 y 46.0 17.2 0 8.7 28.1 10 – – – – – + 
138 4 m 4.4 0 2.4 93.1 0 – – – 8 – – + 
1353 1 y 0.4 3.7 89.6 0.3 6.0 – – 9 – 1 – ++ 
1870 1 y 0 0 0 1.0 99.0 – – – – 10 – + 
1138 11 d 29.2 0 0 3.6 67.2 – – – – 7 – + 
1807 L pr2) 17.2 2.0 52.8 2.0 26.1 – – – – – 10 –  
1370 4 m 22.0 0 30.9 2.1 45.0 – – 1 – 7 – ++ 
1391 2 y 42.9 4.9 44.4 7.8 0 – – – 9 – – + 
1384 4 m 22.3 36.9 0.2 0 40.6 – 3 – – – – + 
195 4 d 0 1.4 0 0 98.6 – – – – 8 – + 
1230 4 m 1.1 0.3 0 65.0 33.6 – – – – 10 – + 
1870 4 d 15.0 81.8 3.3 0 0 – 10 – – – – + 
1) All positively transformed colonies per each sample were analyzed 
2) L pr – late pregnancy 
3) ++: more than 1 of the predicted components detected; +: one of the predicted components is 
detected; –: the component, predicted to be absent, was detected 
3.3.3 Average composition of Bifidobacterium species in the stool 
samples 
A graphical representation of average composition of Bifidobacterium species in stool 
samples of infants and their mothers is presented in Figure 3.7. Stool samples from pregnant 
women were predicted to be rich in B. adolescentis, B. bifidum and B. longum, while B. breve 
and B. dentium were present in smaller amounts. Right after birth and up to 4 months of age, 
Bifidobacterium species were dominated by B. longum and B. breve. The B. longum group 
had its peak at 10 days of age comprising 57 % of bifidobacterial microbiota at this age. 
Interestingly, B. breve separated all 10-day-old infants in two distinct groups. In one group, it 
was accounting for less than 15 %, whereas in the other for more than 75 % of the 
bifidobacterial load. There was no single infant who had an intermediate abundance of B. 
breve between the two values at this age. By the age of 4 months, B. breve increased in its 
abundance in many infants, and, in average, it became predominant, whereas B. longum 
remained on the level of 38 % from this time on. After 4 months, B. breve and B. adolescentis 
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became negatively correlated, as one decreased, reaching the level of 7.0 % by the age of 2 
years, while the other increased up to 28.3 %. Highest fluctuations in the percentages were 
exhibited by B. longum, B. breve and B. adolescentis. B. dentium seemed to be rather stable in 
time, whereas B. bifidum showed a decrease from birth up to 10 days and then increased its 
abundance, reaching levels of around 20 % by 1-2 years (Appendix E).  
 
Figure 3.7 Relative Bifidobacterium species composition and their change over time in stool 
samples of infants (from 3 days to 2 years of age) and their mothers during pregnancy. 
Significance of the changes were tested using the Kruskal-Wallis test. *p<0.05; **p<0.01; 
***p<0.001. 
Relative to the total microbial load, fluctuations in B. adolescentis were masked by the overall 
development of the whole Bifidobacterium group, which showed a remarkable decrease from 
59.3 % at the age of four months to 10.8 % and further to 6.7 % at 1 and 2 years, respectively 
(Appendix E). Here, B. adolescentis levels also remained quite stable over time, leaving most 
of fluctuations to B. longum, B. breve and B. bifidum (Figure 3.8).  
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Figure 3.8 Bifidobacterium species composition and their change over time relative to the 
total gut microbiota in stool samples of infants (from 3 days to 2 years of age) and their 
mothers during pregnancy. Significance of the changes were tested using the Kruskal-
Wallis test. *p<0.05; **p<0.01; ***p<0.001. 
3.3.4 Local Similarity Analysis  
Relative to the remaining Bifidobacterium species, abundance of B. adolescentis seemed to be 
in synch with that of B. bifidum and opposite to that of B. breve. At the same time, the 
development of B. longum and B. breve appeared to be counter-indicative of B. bifidum, 
although there was a two time point delay between B. bifidum and B. breve. Relative to 
Bifidobacterium, B. dentium supposedly developed independently of other dominant species 
(Figure 3.9).  
 
Figure 3.9 Network interactions and local 
similarity scores between dominant 
Bifidobacterium species. Only interactions 
with a p-value of less than 0.05 are presented. 
**p<0.01. 
For the LSA relative to the total bacterial load, outer bacterial groups were also taken into 
consideration. Here, B. dentium, B. breve and B. bifidum seemed to show a positive 
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correlation with each other, whereas the abundance of B. longum was only found to correlate 
with that of B. breve, compared to the remaining Bifidobacterium species. However, with 
respect to other residents of the gut, B. longum showed the correlation with Lactobacillales, 
other Bacilli, Clostridia and Proteobacteria groups (Figure 3.10). Interestingly, relatively to 
Bifidobacterium, B. bifidum seemed to exhibit a negative time-delayed correlation to B. breve, 
whereas relative to the total microbial load, abundances of these bacteria developed in the 
same direction.  
 
Figure 3.10 Network interactions and local 
similarity scores between dominant 
Bifidobacterium species and other bacterial 
groups. Percentages shown are relative to the 
total microbial load. Only interactions with a p-
value of less than 0.05 are presented.**p<0.01. 
3.3.5 Presence/absence test 
The abundance of Bifidobacterium load in mothers was not correlated to that of their newborn 
infants as revealed by Fisher’s Exact test performed on binarized data.  Plotting the MCR 
predicted abundances of dominant species in stool samples from infants against that from the 
mothers also suggested independence (Appendix H). 
3.3.6 B. longum group composition 
There was a high concordance between MCR-ALS predictions of the B. longum group and 
whether or not the sequence was obtained with clpC-L primer – the B. longum group was 
detected in 214 samples out of 280 predicted by MCR-ALS, and was not detected in 49 out of 
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92 where it was predicted to be absent (p = 8.99*10
-8
). For this calculation, the sequence was 
regarded as predicted to be present by MCR-ALS if the percentage of the B. longum group 
was predicted to be equal to or more than 6.5 % (mean RMSEP for the B. longum group, 
Table 3.3). In total, the B. longum group was detected in 80 % of all samples, with the 
smallest number of sequences belonging to the 3 day-old infants (73 % of all individuals in 
whom Bifidobacterium spp. were identified) and highest number to 2-year-old children (98 % 
of all individuals in whom Bifidobacterium spp. were identified). The sequences obtained 
were pure and thus MCR-ALS analysis was not performed. Instead, all the sequences were 
collectively aligned and inspected manually. Most of them belonged to the B. longum longum 
species. In total, there were 39 sequences with more than 3 nucleotide variations compared to 
the multiple alignment consensus, out of which only 13 had a nucleotide variation pattern 
resembling that of B. longum infantis, and 5 sequences lacked one or two of nucleotide 
variations between B. longum longum and B. longum infantis (for the list of nucleotide 
variations, see Appendix C). Sequences with a similar nucleotide variation pattern were 
aligned together and the consensus sequence of the alignment was searched against the NCBI 
nucleotide database using BLAST (Appendix F). One of the clusters could not be assigned to 
any of B. longum group species, therefore, henceforth in this thesis, these sequences will be 
referred to as Unclassified. Sequences which were identified as B. longum longum, but had 3 
or more nucleotide variations compared to the reference B. longum longum sequence will be 
referred to as B. longum unclassified. Those that lacked one or two nucleotide variations 
between B. longum longum and B. longum infantis, will be denoted B. longum infantis – like 
B. longum; and sequences possessing all nucleotide variations will be referred to as B. longum 
infantis. Two sequences belonging to B. longum infantis–like B. longum were identified as B. 
longum suis. 
The maximum likelihood phylogenetic tree of 39 extracted sequences together with reference 
sequences of B. adolescentis, B. dentium, B. bifidum, B. breve, B. longum longum and B. 
longum infantis is presented in Figure 3.11. Most of these 39 sequences originated from the 
stool samples of 10-day- and 4-month-old children, and only one came from a pregnant 
woman. 
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Figure 3.11 Maximum likelihood phylogenetic tree (phyML) of B. longum sequences that 
had more than 3 nucleotide variations compared to the consensus of all aligned B. longum 
sequences. Multiple alignment was performed using the MUSCLE algorithm. Prior to 
phylogenetic reconstruction, all sequences were pairwise aligned to predefined start and 
end regions and trimmed. Reference sequences are highlighted in bold. The tree was 
constructed using the Phylogeny.fr online tool (Dereeper A., Guignon V. et al., 2008) and 
visualized with Dendroscope (Huson D. et al., 2007).*The reference sequence for 
B.longum longum also represents 238 sequences which had no nucleotide variations 
compared to the reference sequence. 
Only B. longum longum was detected in all pregnant women, except for one mother, who had 
B. longum unclassified (Figure 3.12). Right after birth, one baby harbored an unclassified 
sequence and one, the offspring of the mother with B. longum unclassified, had a sequence 
belonging to the same subgroup as the mother. From 10 days of age, though still being the 
most common subgroup, B. longum longum exhibited a decreasing prevalence, being found in 
71 % and 64 % of children at 10 days and 4 months, respectively. At the same time, the 
unclassified subgroup was found in 11 % (10 days) and 7 % (4 months) of children. Most of 
B. longum infantis sequences were characteristic for children aged 4 months – there was only 
one baby, in which it was detected earlier, and only two, where it persisted up to 1 year of 
age. By the age of 2 years, B. longum longum seemed to be regaining its prevalence as it was 
found in 59 out of 61 children. 
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Figure 3.12 Prevalence of B. longum group species at different ages. 
Numbers of samples where bacterial species were detected is given as a 
percentage (y – axis). Pregn1 and pregn2 – early and late pregnancy 
periods; 3d, 10d, 120d, 360d and 720d – 2 – 4 days, 10 days, 4 months, 1 
year and 2 years of age, respectively. 
To check whether there is a concordance between the B. longum sequence of the mother and 
that of the child during the first days of his/her life, sequences of mother/infant were pairwise 
aligned and compared. There were only nine such pairs, out of which only four had 100 % or 
99 % identity (Appendix H).  
3.3.7 Competition test 
To investigate whether B. longum longum and B. longum infantis were outcompeted by one 
another during infancy, we decided to perform a competition test with a one carbon-source 
semi-synthetic medium. Due to the fact that human milk oligosaccharides are extremely 
difficult to purify and are commercially unavailable, we chose to use lactose and lacto-N-
biose, which is broadly known as a proxy for HMOs (Nishimoto M. et al., 2007), as single 
carbon sources. Unfortunately, isolation of Bifidobacterium spp. strains from IMPACT stool 
samples was unsuccessful. The experiment was performed twice with Bereens medium and 
Wilkins-Chalgren for Bifidobacterium Mupirocin medium (Chapter 2.7.1). There were no 
colonies observed on plates, inoculated with 1:100 and 1:1000 dilutions of stool samples, 
whereas colonies on 1:10 dilution plates belonged to Lactobacillus paracasei and 
Lactobacillus casei, as shown by sequencing of 16S rRNA gene amplicons. Therefore pure 
cultures of B. longum longum (DSM20219) and B. longum infantis (DSM20088) were 
obtained from the German Collection of Microorganisms and Cell Cultures. The competition 
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experiment was performed twice. However, the results were inconclusive (Appendix G). Due 
to the time constraints the experiment was not repeated. 
3.4 Correlation between environmental factors and 
Bifidobacteria composition 
3.4.1 Description of the factors 
Seventeen factors which might potentially have an impact on the development of the 
Bifidobacterium spp. were selected. Correlations of Bifidobacterium species’ abundance 
measured at one time point, and those of the changes in their abundance between two 
subsequent time points to these factors were calculated. To minimize the risk of statistical 
error, only those factors which had no less than 4 individuals in each of the factor-separated 
groups at any given time point were regarded. Moreover, we omitted factors in which the 
number of individuals in one factor-separated group was more than twice higher than in the 
other. There were only six factors which met both of these criteria. Number of samples in 
each of the time point in various groups tested is presented in Appendix J and K.  
Four of the factors with sufficient numbers of samples relate to the mother’s health and diet 
during pregnancy. As for the children’s lifestyles, only multivitamin intake and breast-feeding 
had enough of samples to minimize the risk of statistical error. Information on infant lifestyles 
was gathered from the questionnaires filled out by parents during pregnancy, and when their 
children were 6 weeks, 1 year and 2 years old. Both for breast-feeding and multivitamin 
intake, we only knew that the number of samples in each group was not enough for the groups 
separation at 6 weeks, but sufficient enough for the later separation (1 year). Taking into 
account that stool samples were taken at 10 days, 4 months 1 and 2 years age, we assumed 
that the change was introduced somewhere after 4 months and therefore only the time points 
of 1 and 2 years were considered.  
The cross-correlation between every pair of factors was checked using the Pearson’s chi-
square test (Appendix I). Generally, the factors were not cross-correlated. However, the 
positive correlation between vegetable consumption and common-cold-infections during 
pregnancy were detected: 15 out of 17 women who reported common-cold-infections ate 
vegetables more than 4 times a week, whereas 18 out of 36 which didn’t report such 
infections, ate vegetables less regularly (p = 0.007).  
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3.4.2 Fish oil supplement during pregnancy 
Relative both to Bifidobacterium spp. and to total bacterial load, mothers receiving a fish oil 
supplement during pregnancy did not show any significant correlation to the composition of 
Bifidobacterium species at any given time point. However, the change in the abundance of B. 
longum and B. breve over time was significantly different in infants whose mothers ingested 
fish oil during their pregnancy. 
Relative both to Bifidobacterium spp. and to the total bacterial load, B. breve showed a higher 
increase from 10 days to 4 months of age in a group of children whose mothers consumed a 
fish oil supplement during pregnancy. Relative to the total bacterial load, the change in the 
abundance of B. longum during the same period of time was negative in the group of children 
whose mothers ingested a fish oil supplement, and positive in the group of children whose 
mothers did not. Relative to Bifidobacterium spp., however, B. longum levels showed a 
reduction in both groups, but the decrease was higher in infants of mothers with fish oil-
supplemented diets (Table 3.7). 
Table 3.7 Average change in the abundance of MCR-predicted Bifidobacterium species in 
infants from 10 days to 4 months of age 
MCR-predicted bacterial 
species, relative to
1)
 
Average change , % (SEM)
 2)
 
Taking fish oil supplement during the pregnancy 
Yes No 
B. breve 
B*
3)
 42.79 (14.28) 11.40 (12.39) 
TL* 36.24 (11.19) 11.47 (7.43) 
B. longum 
B* -38.85 (11.66) -5.66 (13.08) 
TL* -15.37 (9.35) 9.37 (9.66) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) * 0.01 ≤  p ≤ 0.05 
 
3.4.3 Consumption of vegetables during pregnancy 
There were no observed differences in the relative levels of Bifidobacterium spp. in the 
samples that could be correlated to whether pregnant mothers ate vegetables on a nearly daily 
basis (four times a week or more), or not.  However, relative to the total bacterial load, the 
abundance of B. breve was higher in a group of newborns (2-4 days old) whose mothers did 
not eat vegetables regularly during their pregnancy (Table 3.8). The same was true for the B. 
bifidum percentage levels in 10 day-old individuals.  
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As for the development over time, there were many samples belonging to infants of mothers 
who ate vegetables regularly, but only few of those, who were not. Therefore no information 
on significant difference in change over time between two groups of individuals could be 
deduced. 
Table 3.8 Average abundance of MCR-predicted Bifidobacterium species relative to the 
total bacterial load, in infants whose mothers did or did not eat vegetables more than 4 
times a week, respectively 
MCR-predicted bacterial species, 
relative to
1) 
Average abundance, % (SEM)
2) 
Mothers ate vegetables more than 4 times a week 
Yes No 
2 – 4 days 
B. breve* TL*
3)
 0.78 (0.40) 7.87 (4.27) 
10 days 
B. bifidum* TL* 1.72 (0.57) 4.11 (1.26) 
1) TL – relative to the total bacterial load; 
2) SEM – standard error of the mean; 
3) * 0.01 ≤  p ≤ 0.05 
3.4.4 Reported common cold infection during pregnancy 
The reporting of common cold infection during pregnancy exhibited correlation to both 
mothers’ and children’s composition of Bifidobacterium species. The abundance of B. 
adolescentis relative both to Bifidobacterium spp. and to the total bacterial load was 
significantly lower in mothers who reported common cold infection during their pregnancy 
(Table 3.9). Also, relative to the total bacterial load, mothers who reported having had a cold 
during pregnancy showed correspondence with their newborn infants regarding the abundance 
of B. adolescentis (Table 3.10). 
B. breve was less abundant in the group of 10-day-old children whose mothers reported 
having had a cold. However, at four months, B. breve levels were higher in the same group 
(Table 3.9). Interestingly, the change in the relative abundance of B. breve was significantly 
different between the two groups of children (whose mothers did or did not reportedly have a 
cold during their pregnancy) from birth up to four months. Shortly after birth, from 2 – 4 to 10 
days of age, B. breve levels decreased in the cold group, while showing an increase in the 
healthy group both relative to Bifidobacterium spp. and total bacterial loads. As for the period 
from 10 days to 4 months of age, the relative abundance of B. breve increased in both groups, 
though the extent was higher in the group of children whose mothers reportedly suffered from 
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a cold during pregnancy (Table 3.10). Relative both to total bacterial and Bifidobacterium 
spp. load, even at 2 years of age, the abundance of B. breve was significantly lower in the 
group of children, whose mothers reportedly had a cold during pregnancy (Table 3.9).  
Table 3.9 Average abundance of MCR-predicted Bifidobacterium species in infants whose 
mothers did/did not report having had a cold during pregnancy. 
MCR-predicted bacterial species, relative 
to
1) 
Average abundance, % (SEM)
2) 
Mothers reported a cold during pregnancy 
Yes No 
Early pregnancy 
B. adolescentis 
B**
3) 31.38 (12.09) 55.65 (5.55) 
TL* 0.83 (0.40) 2.16 (0.42) 
Late pregnancy 
B. adolescentis TL* 0.67 (0.27) 2.94 (1.32) 
2 – 4 days 
B. breve B* 3.87 (2.01) 26.67(8.28) 
B. longum B* 76.61(10.84) 41.71(10.58) 
10 days 
B. bifidum 
B** 15.25 (3.73) 4.94 (1.59) 
TL* 3.96 (1.34) 1.43 (0.60) 
B. breve 
B** 9.06 (6.35) 40.34 (11.64) 
TL** 4.46 (2.90) 22.84 (7.14) 
B. longum B* 62.77 (8.64) 35.84 (10.38) 
4 months 
B. breve TL* 44.97 (9.08) 22.87 (5.38) 
2 years 
B. breve 
B* 2.16 (0.57) 9.23 (2.64) 
TL** 0.1 (0.06) 1.06 (0.48) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
Mothers reporting having had a cold during pregnancy correlated to elevated levels of the B. 
longum group relative to Bifidobacterium spp., both during late stages of pregnancy and 
during early days of infants’ lives (Table 3.9). B. bifidum was also elevated in 10 day-old 
babies whose mothers reportedly had suffered from a cold. Relative to the total bacterial load, 
the change in the relative abundance of B. dentium from 10 days to 4 months of age was 
negative in infants whose mothers had reported a cold and positive in those who had not 
(Table 3.10). 
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Table 3.10 Average change in the abundance of MCR-predicted Bifidobacterium species 
in infants whose mothers did/did not report having had a cold during pregnancy 
MCR-predicted bacterial species, 
relative to
1) 
Average change, % (SEM)
2) 
Mothers reported a cold during pregnancy 
Yes No 
From late pregnancy to a newborn 
B. adolescentis TL*
3)
 -0.77 (0.28) -2.92 (1.52) 
From 2 – 4 days to 10 days 
B. breve 
TL** -0.66 (0.66) 26.00 (7.87) 
B* -3.46 (2.57) 23.40 (10.10) 
From 10 days to 4 months 
B. breve TL** 40.92 (11.28) 9.82 (8.58) 
B. dentium TL* -0.34 (0.44) 2.21 (1.34) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
A summary of the correlation between mothers reporting having had a cold during pregnancy 
to the relative composition and change in time of MCR-predicted Bifidobacterium species of 
mothers and their infants is presented in Figure 3.13. 
 
Figure 3.13 Correlation of mothers reporting having had cold during pregnancy to the 
abundance and the development of Bifidobacterium species in stool samples of mothers and 
their infants. Two groups of infants and their mothers are color-coded as: red – reported a 
cold during pregnancy; blue – did not report a cold during pregnancy. Time points, where no 
significant difference was observed, are colored grey. Colored parallelograms represent 
groups with significantly higher abundance relative to Bifidobacterium spp.; ellipses – relative 
to the total bacterial load. Triangles depict the situation, when the observed difference in the 
change between the two groups was significant. Triangle pointing to the top (or bottom) 
means that the abundance increased (or decreased) in both groups, but the rate was higher 
in a colored group. The combination of two triangles – two groups developed in opposite 
directions. The orientation of the triangle shows the direction of the change in both groups. 
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3.4.5 Reported vaginal fungal infection during pregnancy 
For at least one time point, all MCR-predicted Bifidobacterium species in mothers and their 
infants seemed to correlate to whether mothers reported having had a vaginal fungal infection 
during pregnancy. The correlation was strongest relative to the total bacterial load, whereas 
relative to Bifidobacterium spp., there was only one case when a significant difference 
between the two groups was detected; 2-year-old children, whose mothers had reported a 
vaginal fungal infection, had a lower abundance of B. bifidum compared to the group of 
children whose mothers were reportedly healthy during pregnancy (Table 3.11). The change 
in the relative abundance of these species also developed in opposite directions in the two 
groups of infants from 1 to 2 years age. Relative to the total bacterial load, the difference in 
the change of B. bifidum from 10 days to 4 months of age was observed (Table 3.12). During 
the same period, the abundance of B. breve increased in all children, however, the rate of 
increase was higher in infants whose mothers had reported a fungal infection (Table 3.12).  
Table 3.11 Average abundance of MCR-predicted Bifidobacterium species in infants whose 
mothers did/did not reportedly suffer from a vaginal fungal infection during pregnancy. 
MCR-predicted bacterial species, 
relative to
1) 
Average abundance, % (SEM)
2) 
Mother reported a vaginal fungal infection during 
pregnancy 
Yes No 
Late pregnancy 
B. adolescentis TL**3) 3.44 (0.60) 0.67 (0.35) 
2 – 4 days 
B. dentium TL* 1.89 (0.90) 0.23 (0.16) 
10 days 
B. longum TL** 39.11 (11.64) 12.68 (4.27) 
1 year 
B. longum TL** 1.61 (0.63) 5.69 (1.78) 
All Bifidobacterium spp. TL* 4.18 (0.99) 10.52 (2.24) 
2 years 
B. bifidum B* 16.90 (4.77) 30.15(3.49) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
Fungal infections during pregnancy also correlated with elevated levels of B. adolescentis 
during the late pregnancy stage and with B. dentium levels in newborn babies (Table 3.11). 
During pregnancy, the abundance of B. dentium relative to Bifidobacterium spp. decreased in 
mothers who had reportedly suffered from infection, and increased in those, who had not 
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(Table 3.12). Relative both to Bifidobacterium spp. and to the total bacterial load, the 
abundance of B. adolescentis in newborns seemed to resemble that of mothers more in the 
reportedly healthy group compared to the reportedly infected group.  
Table 3.12 Average change in the abundance of MCR-predicted Bifidobacterium species in infants 
whose mothers did/did not reportedly suffer from a vaginal fungal infection during their pregnancy. 
MCR predicted bacterial species, 
relative to
1) 
Average change, % (SEM)
2) 
Mother was reportedly suffering from vaginal fungal 
infection during pregnancy 
Yes No 
From early to late pregnancy 
B. longum TL*
3)
 0.50 (0.37) -0.24 (0.11) 
All Bifidobacterium spp. TL* 2.34 (2.09) -0.66 (0.71) 
B. dentium B* -2.81 (1.15) 1.20 (1.76) 
From late pregnancy to a newborn 
B. adolescentis 
TL* -2.99 (1.45) -0.70 (0.43) 
B* -62.79 (2.87) -33.94 (18.31) 
All Bifidobacterium spp. TL* 19.70 (9.03) 2.99 (1.34) 
From 2 – 4 days to 10 days 
B. longum TL** 38.04 (13.93) 2.31 (6.60) 
All Bifidobacterium spp. TL* 42.82 (10.06) 20.81 (7.26) 
From 10 days to 4 months 
B. breve TL* 38.71 (10.57) 8.70 (9.07) 
B. bifidum TL* 1.60 (1.86) 10.04 (4.55) 
B. longum 
TL** -26.63 (11.68) 21.05 (9.33) 
B** -45.95 (12.35) 5.03 (14.57) 
From 1 to 2 years 
B. longum TL** 3.84 (2.65) -3.69 (1.81) 
All Bifidobacterium spp. TL* 5.86 (2.60) -3.74 (2.93) 
B. bifidum B* -12.67 (8.04) 3.08 (5.02) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
Noticeably, reports of vaginal fungal infection mostly correlated to the change in the 
abundance of both all Bifidobacterium and B. longum species. All together, significant 
differences were observed in every period over time except for the change from 4 months to 
one year (Table 3.12). Changes in the abundance of Bifidobacterium spp. in general, and B. 
longum in particular, in mothers who had reported a fungal infection during pregnancy were 
opposite to those observed in the reportedly healthy group. The same was true for the 
development of these bacteria in infants from 1 to 2 years of age. In one-year-old children, the 
relative levels of all Bifidobacterium spp. strains and B. longum were lower in the fungal 
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group (Table 3.11). During early infancy (from 3 to 10 days), B. longum increased in its 
abundance in both groups of children, but the rate was higher in the fungal group. Also, 10-
day-old children, whose mothers reported having had a fungal infection during pregnancy, 
exhibited higher levels of B. longum relative to the total bacterial load. Moreover, the 
development of B. longum from 10 days to 4 months showed opposite trends in the two 
groups of children. 
The correlation of having reported a vaginal fungal infection during pregnancy to the 
abundance and development of MCR-predicted Bifidobacterium species is summarized in 
Figure 3.14. 
 
Figure 3.14 Correlation of reportedly having had a vaginal fungal infection during 
pregnancy to the abundance and the development of MCR-predicted Bifidobacterium 
species in stool samples of infants and their mothers. Two groups of infants and their 
mothers are color-coded as: red – reported a fungal infection during pregnancy; blue – 
did not report a fungal infection during pregnancy. Time points, where no significant 
difference was observed, are colored grey. Colored parallelograms represent groups 
with significantly higher abundance relative to Bifidobacterium spp.; ellipses – relative 
to the total bacterial load. Triangles depict the situation, when the observed difference 
in the change between the two groups was significant. Triangle pointing to the top (or 
bottom) means that the abundance increased (or decreased) in both groups, but the 
rate was higher in a colored group. The combination of two triangles – two groups 
developed in opposite directions. The orientation of the triangle shows the direction of 
the change in both groups. 
3.4.6 Breast-feeding throughout the first year of life 
Relative to the total bacterial load, levels of B. bifidum were elevated in those 1- and 2-year-
old children, who were breast-fed through the whole first year of life (Table 3.13). However, 
relative to Bifidobacterium spp., the only significant difference was observed in 1-year-old 
children. B. breve and B. dentium also had higher counts in the breast-fed group of 2-year-old 
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children with regards to total microbial load. The Bifidobacterium spp. group was more 
abundant in 1-year-old breast-fed children. 
No significant difference in the change of Bifidobacterium species’ abundance from 1 to 2 
years depending on the breast-feeding status was detected. A summary of the correlation of 
breast-feeding to the relative abundance of bifidobacterial species is presented in Figure 3.15. 
Table 3.13 Average abundance of MCR-predicted Bifidobacterium species in infants who 
were/were not breast-fed throughout the first year of life 
MCR predicted bacterial species, 
relative to
1) 
Average abundance, % (SEM)
2) 
Breast-fed through the whole first year of life 
Yes No 
1 year 
B. bifidum 
TL**
3)
 4.79 (2.34) 0.58 (0.20) 
B* 28.86 (7.12) 15.75 (4.33) 
All Bifidobacterium spp. TL* 13.18 (4.21) 5.23 (0.95) 
2 years 
B. bifidum TL** 3.70 (2.15) 0.83 (0.25) 
B. breve TL* 1.22 (0.70) 0.16 (0.08) 
B. dentium TL* 0.33 (0.18) 0.10 (0.04) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
 
Figure 3.15 Correlation of breast-feeding throughout the first year of 
life to the abundance of MCR-predicted Bifidobacterium species in 
stool samples of infants. The group of infants who were breast-fed 
throughout the first year of life is color-coded green. Time points, 
where no significant difference was observed, are colored grey. 
Colored parallelograms represent time points where significantly 
higher abundance was observed in individuals belonging to the 
breast-fed group relative to Bifidobacterium spp.; ellipses – relative to 
the total bacterial load.  
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3.4.7 Receiving a multivitamin supplement during the first year of 
life 
Relative to the total bacterial load, no correlation between vitamin intake and bifidobacterial 
composition was observed, whereas relative to Bifidobacterium spp., both 1- and 2-year-old 
children who had received multivitamins exhibited elevated levels of B. bifidum and 
decreased levels of B. longum (2-year-old children) (Table 3.14). However, abundances were 
distributed evenly along the abundance axis regardless of multivitamin intake (Appendix J). 
Surprisingly, relative both to Bifidobacterium spp. and to the total bacterial load, levels of B. 
breve were higher in those 10-day-old babies who had received multivitamins compared to 
those who had not (36.25 % and 4.43 % for yes- and no-groups relative to the total bacterial 
load, and 64.24 % and 9.17 % for yes-and no-groups relative to Bifidobacterium spp.; p < 
0.001 in both cases; Appendix J). For the period from age 1 to 2 years, having received a 
multivitamin supplement correlated to changes in both the amount of B. adolescentis relative 
to Bifidobacterium spp. and B. longum relative to the total bacterial load (Table 3.15). 
Table 3.14 Average abundance of MCR-predicted Bifidobacterium species  
MCR predicted bacterial 
species, relative to
1) 
Average abundance, % (SEM)
2) 
Received a multivitamin supplement during the first year 
Yes No 
1 year 
B. bifidum* B*
3)
 30.99 (7.04) 17.55 (4.82) 
2 years 
B. bifidum* B* 32.89 (4.13) 20.52 (4.79) 
B. longum* B* 28.45 (7.21) 50.49 (7.54) 
1) B – relative to Bifidobacterium spp.; 
1) SEM – standard error of the mean;  
2) *0.01 ≤  p ≤ 0.05 
Table 3.15 Average change in the abundance of MCR-predicted Bifidobacterium species from age 
1 to 2 years in infants who were/were not given a multivitamin supplement during the first year of 
their life 
MCR predicted bacterial 
species, relative to
1)
 
Average change, % (SEM)
2)
 
From 1 to 2 years 
Received a multivitamin supplement during the first year 
Yes No 
B. adolescentis B**
3)
 37.68 (10.37) 6.58 (7.32) 
B. longum TL** 3.80 (4.54) -3.44 (2.09) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) **0.005 ≤  p ≤ 0.01 
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A summary of the correlation of multivitamin intake during the first year of life to the 
abundance and the development of MCR-predicted Bifidobacterium species is presented in 
Figure 3.16. 
 
Figure 3.16 Correlation of having received a multivitamin supplement to the abundance 
and the development of MCR-predicted Bifidobacterium species in stool samples of 
infants. Two groups of infants are color-coded as: green – had received multivitamins 
during the first year of life; blue – had not received multivitamins. Time points, where no 
significant difference was observed, are colored grey. Colored parallelograms represent 
groups with significantly higher abundance relative to Bifidobacterium spp.; ellipses – 
relative to the total bacterial load. Triangles depict the situation, when the observed 
difference in the change between the two groups was significant. Green triangles pointing 
upwards indicate that the abundance increased in both groups, but the rate was higher in 
a group of infants who had received multivitamins. The combination of two triangles – two 
groups developed in opposite directions. The orientation of the triangle shows the 
direction of the change in both groups. 
3.5 Correlation of Bifidobacterium spp. composition to 
allergy and eczema status by two years of age  
3.5.1 Description of clinical criteria 
The allergy and eczema status of children by the age of two years were compared to the 
relative amounts of Bifidobacterium species in their stool samples. With regard to 
sensitization, three concentrations of specific IgE serum were considered: IgE ≥ 0.1 kU/l; IgE 
≥ 0.35 kU/l and IgE ≥ 0.7 kU/l. Eczema was assessed both using UK Working Party criteria 
and mothers’ answers to a questionnaire asking whether or not the baby had experienced 
symptoms of eczema dermatitis during his/her first two years of life.  
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The cross-correlation between two health status criteria of infants was checked using 
Pearson’s Chi-square test. Positive correlation between three IgE levels was detected. Medical 
diagnosis of eczema correlated to the parents’ answers on whether or not the child 
experienced eczema symptoms (Appendix I). No correlation between the any of the three 
examined IgE levels and eczema was observed. We also checked for correlation between 
environmental factors and health status of the infant by the age of two years. There was a 
positive correlation between breast-feeding of the child throughout the first year of life and 
his/her serum IgE level by the age of two years (Appendix I). 
3.5.2 IgE sensitization 
Relative to the total bacterial load, the amount of B. breve was slightly higher in mothers 
whose children exhibited IgE levels ≥ 0.1 kU/l, as well as in 2-year-old children with specific 
IgE levels of more than 0.35 kU/l (Table 3.16). The amount of B. bifidum relative to 
Bifidobacterium spp. was elevated in 10-day-old children with IgE levels under the detection 
limit. From 1 to 2 years, the amount of this species increased in infants with an IgE level of 
more than 0.35 and 0.70 kU/l and decreased in a non-sensitized group (Table 3.17). Relative 
to the total bacterial load, the amount of B. longum in stool samples of sensitized newborns 
resembled that of their mothers’ more than in nonsensitized, where it was higher (Table 3.17). 
B. adolescentis levels were elevated in sensitized 4-month-old children with both high and 
moderate IgE levels relative not only to a Bifidobacterium spp., but also to the total bacterial 
load (Table 3.16). From 10 days to 4 months, the abundance of B. adolescentis increased in 
sensitized (IgE ≥ 0.35 kU/l and 0.7 kU/l), and diminished in non-sensitized children (Table 
3.17). Relative to total bacterial load during this period, however, a significant difference was 
only detected in children with IgE ≥ 0.35 kU/l. From 4 months to 1 year of age, however, the 
abundance of B. adolescentis decreased in sensitized children (IgE ≥ 0.7 kU/l) and increased 
in nonsensitized individuals. 
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Table 3.16 Average abundance of MCR-predicted Bifidobacterium species in sensitized and 
nonsensitized children and their mothers  
MCR predicted bacterial 
species, relative to
1) 
Age category 
Average abundance, % (SEM)
2) 
Specific serum IgE ≥ Threshold 
Yes No 
Threshold – 0.10 kU/l 
B. breve TL*
3)
 Late pregnancy 0.04 (0.02) 0.01 (0.01) 
B. bifidum B* 10 days 4.61 (1.41) 12.27 (2.63) 
Threshold – 0.35 kU/l 
B. breve TL* 2 years 1.51 (0.76) 0.30 (0.10) 
B. adolescentis B* 4 months 10.04 (4.89) 2.24 (0.78) 
Threshold – 0.70 kU/l 
B. adolescentis  
TL* 
4 months 
4.07 (2.13) 1.32 (0.44) 
B** 12.22 (5.89) 2.12 (0.73) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
Table 3.17 Average change in the abundance of MCR-predicted Bifidobacterium spp. in sensitized and 
nonsensitized children 
MCR predicted bacterial 
species, relative to
1) 
Time period 
Average change, % (SEM)
2) 
Specific serum IgE ≥ Threshold 
Yes No 
Threshold – 0.10 kU/l 
B. longum TL*
3)
 Late pregn – 2-4 days -0.4 (0.28) 5.99 (1.47) 
B. adolescentis B** 10 days – 4 months 4.35 (2.72) -5.02 (3.87) 
B. breve B* 10 days – 4 months 1.95 (12.68) 41.88 (11.68) 
Threshold – 0.35 kU/l 
B. adolescentis 
TL* 
10 days – 4 months 
2.77 (2.00) -3.23 (2.64) 
B** 4.98 (3.16) -4.65 (3.66) 
B. longum TL* Late pregn – 2-4 days -0.4 (0.28) 5.98 (1.47) 
B. bifidum B* 1 year – 2 years 6.41 (5.35) -8.59 (4.46) 
Threshold – 0.70 kU/l 
B. adolescentis 
B* 10 days – 4 months 6.57 (4.12) -3.93 (3.12) 
B* 
4 months – 1 year 
-4.52 (11.96) 15.87 (4.25) 
TL* -4.98 (3.19) 0.20 (0.71) 
B. bifidum B* 1 year – 2 years 8.79 (10.00) -8.34 (3.09) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
Relative to the total bacterial load, the abundance of B. longum in newborns with IgE ≥ 0.1 
kU/l and 0.35 kU/l resembled its abundance in mothers more than in nonsensitized infants 
(Table 3.17). 
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A summary of the correlation between the abundance and the development of MCR-predicted 
Bifidobacterium species to specific serum IgE levels is presented in Figure 3.17. 
 
Figure 3.17 Age categories, in which differences in the relative amounts of 
Bifidobacterium species between sensitized/nonsensitized children and their 
mothers were significant. Two groups of infants and their mothers are color-
coded as: IgE levels higher than 0.1 kU/l, 0.35 kU/l, 0.7 kU/l or the combination 
of them – see the color-coding circle; blue – no allergy. Time points, where no 
significant difference was observed, are colored grey. Colored parallelograms 
represent groups with significantly higher abundance relative to Bifidobacterium 
spp.; ellipses – relative to the total bacterial load. Triangles depict the situation, 
when the observed difference in the change between the two groups was 
significant. Triangle pointing to the top (or bottom) means that the abundance 
increased (or decreased) in both groups, but the rate was higher in a colored 
group. The combination of two triangles – two groups developed in opposite 
directions. The orientation of the triangle shows the direction of the change in 
both groups. 
3.5.3 Eczema status 
Relative to the Bifidobacterium spp. load, children whose eczema status was confirmed 
medically had higher amounts of B. dentium during the early days of their lives (10 days). 
Also, mothers of these babies showed elevated levels of B. bifidum during late pregnancy 
(Table 3.18). Relative to the total bacterial load, abundances of B. dentium, B. longum and all 
Bifidobacterium species were higher in 1-year-old children with medically diagnosed eczema. 
The relative amount of B. longum in stool samples of 10-day-old children also correlated to 
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the incidence of eczema, though in this case it was higher in the healthy group without 
eczema (Table 3.18). 
Table 3.18 Average abundance of MCR-predicted Bifidobacterium species in mothers and 
their children who by two years of age developed/did not develop eczema as assessed by UK 
Working Party criteria  
MCR predicted bacterial species, 
relative to
1) 
Average abundance, % (SEM)
2) 
Eczema diagnosed (UKWP) 
Yes No 
Early pregnancy 
B. bifidum B*3) 37.32 (2.94) 22.76 (2.96) 
10 days 
B. longum TL* 6.15 (3.09) 29.09 (5.54) 
B. dentium B* 17.05 (9.70) 2.35 (0.82) 
1 year 
B. dentium TL* 1.08 (0.15) 0.35 (0.22) 
B. longum TL* 7.01 (3.09) 2.54 (5.54) 
All Bifidobacterium spp. TL** 16.88 (4.07) 6.59 (1.33) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
Ten-day-old children with eczema symptoms had higher amounts of B. dentium relative to 
Bifidobacterium spp. (Table 3.19). At 4 months, both B. longum and B. adolescentis were 
elevated in children with eczema symptoms, whereas B. breve was less abundant relative not 
only to Bifidobacterium spp., but also to the total bacterial load (Table 3.19).  
Table 3.19 Average abundance of MCR-predicted Bifidobacterium species in children 
showing/not showing eczema symptoms  
MCR predicted bacterial species, 
relative to
1) 
Average abundance, % (SEM)
2) 
Eczema symptoms (questionnaire) 
Yes No 
10 days 
B. bifidum B*3) 13.75 (2.94) 6.62 (1.92) 
4 months 
B. longum 
TL* 32.70 (7.66) 16.90 (3.52) 
B* 55.33 (9.65) 32.01 (5.63) 
B. breve 
TL* 12.93 (6.48) 31.19 (4.58) 
B* 19.39 (9.34) 50.00 (6.38) 
B. adolescentis 
TL* 3.89 (1.83) 1.25 (0.45) 
B** 11.68 (5.49) 2.06 (0.73) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
 60 
 
There was no difference detected in the change of Bifidobacterium species’ abundances in 
children who had eczema symptoms compared to those who did not. However, at some time 
points, the changes in the abundance of B. longum and B. dentium showed opposite trends in 
children with diagnosed eczema compared to healthy individuals (Table 3.20). 
Table 3.20 Average change in the abundance of MCR-predicted Bifidobacterium species in 
children with diagnosed eczema and healthy children  
MCR predicted bacterial 
species, relative to
1) 
Average change, % (SEM)
2) 
Eczema diagnosed (UKWP) 
Yes No 
From 4 days to 10 days 
B. dentium B**
3)
 5.00 (5.85) -5.11 (2.03) 
B. longum TL* -1.74 (8.62) 26.65 (7.41) 
From 1 year to 2 years 
B. longum B* -20.1 (6.77) 12.04 (7.85) 
1) B – relative to Bifidobacterium spp.; TL – relative to the total bacterial load; 
2) SEM – standard error of the mean;  
3) *0.01 ≤  p ≤ 0.05; **0.005 ≤  p ≤ 0.01 
A summary of the correlation between the abundance and the development of MCR-predicted 
Bifidobacterium species to diagnosed eczema, and eczema reported by parents, is presented in 
Figure 3.18. 
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Figure 3.18 Age categories, in which differences in the relative amounts of 
Bifidobacterium species between mothers and their children who had/had not 
suffered from eczema was significant. Two groups of infants and their mothers 
are color-coded as: pink – diagnosed eczema; blue – no eczema diagnosed; 
yellow – eczema reported by parents; green – no eczema reported by parents. 
Time points, where no significant difference was observed, are colored grey. 
Colored parallelograms represent groups with significantly higher abundance 
relative to Bifidobacterium spp.; ellipses – relative to the total bacterial load. The 
combination of two triangles depicts the situation when two groups developed in 
opposite directions. The orientation of the triangle shows the direction of the 
change in both groups. 
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4 Discussion 
4.1 Identification of dominant Bifidobacterium species 
4.1.1 Assessment of MCR-ALS for Bifidobacterium species 
resolution 
The MCR-ALS method for resolving mixed clpC sequence data was verified using 35 
predefined mixtures of four Bifidobacterium species commonly associated with the human 
gut. The approach was proven to be a suitable method for identification and quantification of 
bifidobacterial species in mixtures. However, there was a tendency of overestimating the 
abundance of B. adolescentis and underestimating that of B. breve, whereas the abundance of 
the B. longum group was predicted more accurately. The B. longum group comprised of two 
bacteria, B. longum longum and B. longum infantis, and therefore there was twice as much 
information about this group in mixed sequences than for B. breve and B. adolescentis. This 
may partially explain why the B. longum group was better resolved than the other species. 
During the design and assessment of the method, we encountered many problems with the 
quality of sequences used for the resolution. If not removed, these sequences caused improper 
spectra alignment correction and thus hindered accurate MCR-ALS prediction. Instead of 
removing the samples, we checked the possibility of removing the part of information about 
the sequences that had caused the abnormality. Not only did this not weaken the predictability 
of the method, but even slightly improved MCR-ALS performance by reducing the prediction 
error.  
4.1.2 Prevalence of Bifidobacterium species in stool samples of 
infants and their mothers  
MCR-ALS identified five predominant components in stool samples of infants and their 
mothers from Trondheim – B. adolescentis, B. dentium, B. breve, B. bifidum and B. longum. 
Confirmation of the identified components in the dataset was acheived by cloning and 
sequencing of the cloned amplicons, which showed 98 % – 99 % identity with the 
corresponding GenBank reference sequences. Two MCR-resolved component sequences, 
identified as B. bifidum and B. dentium, showed low similarity to their respective reference 
sequences deposited in GenBank. However taking into account that these species were 
detected by sequencing cloned inserts from the corresponding samples, we suppose that this 
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low similarity was caused by noise. The fact that apart from B. animalis only those 
Bifidobacterium species, which were predicted by MCR-ALS, were identified by sequencing 
of cloned inserts, strongly speaks in favor of correct prediction of Bifidobacterium species. 
We did not identify B. pseudolongum, which is normally associated with a human gut. When 
we searched mixed sequences against NCBI nucleotide database, these species were not 
detected in any of the samples either. The clpC sequences of B. pseudolongum (AY722386.1; 
DQ238019.1; DQ238034.1) deposited in GenBank are short and miss the region of the primer 
binding, so we were unable to check whether the absence was caused by primer bias. 
However, the GenBank-deposited sequences were obtained with the same clpC primers which 
we used for this work (Ventura et al., 2006). Therefore primer bias is unlikely to be the reason 
for the lack of B. pseudolongum in the IMPACT dataset. B. pseudolongum is believed to be 
present exclusively in adults (Ventura et al., 2010a). In our dataset, only 24 % of all samples 
(78 out of 330) represented stool samples from adults, therefore the information about this 
species could have been lost during MCR-ALS analysis, as it probably was not present in 76 
% of the analyzed samples. Interestingly, we also did not detect B. pseudocatenulanum – the 
species which was shown to be present in the human gut irrespective of the age (Turroni et al., 
2009). However, in the Turroni study of 59 healthy individuals of different age, the 
prevalence of B. pseudocatenulanum varied from 3 % to 14 % depending on the age and the 
sample type (stool or mucosal samples). The MCR method searches for components that are 
common for all the samples in the dataset, whereas other information is regarded as noise. 
Therefore, the species of B. adolescentis, B. breve, B. longum, B. bifidum and B. dentium most 
likely comprise the most commonly identified Bifidobacterium species in the gut, while others 
(like B. animalis, which was detected by sequencing all cloned amplicons generated from one 
sample), though still being present, and even possibly being present at high concentrations, 
are not shared in the cohort population. This can also be supported by the fact that only 57 % 
of the variation among the samples is explained by MCR, leaving the rest of it to other 
species, present in some, but not all individuals. 
B. dentium, mostly isolated from oral cavities and believed to be associated with dental caries 
(Tannock, 2010), was identified as one of five the most common components of 
Bifidobacterium group among all 83 individuals examined in this study. However, stool 
samples represent the luminal microbial consortium of the human gut. So, in the study of 
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Turroni et al., they detected B. dentium in stool, but not in mucosal samples, suggesting that 
this species most likely constitutes part of the transient microbiota (Turroni et al., 2009).  
4.2 Average composition of Bifidobacterium species in 
infants and their mothers and the interactions revealed 
We calculated average abundances of the five most common Bifidobacterium species both 
within the Bifidobacterium spp. group and relative to the total microbial load. It has been 
shown by Palmer et al., that the total gut microbiota undergoes crucial changes in its 
development up to the age of 1 year, and then it remains stable over time and resembles that 
of the adult (Palmer et al., 2007). Strikingly, in our data, there were still high changes in 
bifidobacterial composition between 1 and 2 years of age, though development was directed 
towards an adult profile. Palmer et al. detected low prevalence of Bifidobacterium species in 
stool samples of infants. However, for our study population, the presence of Bifidobacterium 
species at all ages was confirmed both by the analysis of 16S rRNA and clpC genes. 
B. dentium was one of the most stable species and its relative load remained nearly the same 
regardless the age. If B. dentium is commonly present in the mouth, then it would most likely 
be transferred constantly to the intestines with food and then excreted. The levels of B. 
dentium, however, suggest some growth of this species in the gut lumen.  
A majority of the adult bifidobacterial load consisted of B. adolescentis. This goes in 
accordance with the fact that B. adolescentis is predicted to have a plant-derived 
oligosaccharides fermentation machinery (Ventura et al., 2007a). In newborns, the average 
levels of B. adolescentis were much lower than in adults, and this species constituted just a 
20
th
 of the whole Bifidobacterium spp. load up to 1 year of age, when it then started 
increasing in abundance towards an adult profile. However, relative to the total bacterial load, 
by the age of 10 days the percentage of B. adolescentis reached the adult level and then 
remained rather stable over time regardless of the change in the total Bifidobacterium spp. 
group. Therefore the commonly accepted view of B. adolescentis as characteristic of an adult 
gut microbiota (Haarman M., Knol J., 2005) might possibly be the result of comparing the 
abundances of the species relative to other Bifidobacterium spp. rather than to the total gut 
microbiota.  
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B. breve was almost exclusively found in infants. B. breve is regarded to be an important 
species during weaning, as amylopullulanase, the enzyme responsible for starch degradation, 
is encoded in its genome (Ventura et al., 2007b). The peak of B. breve abundance was found 
in 4-month-old infants, where it comprised one fifth of the total bacterial load. By the age of 1 
year it diminished and by 2 years, B. breve was nearly absent.  
Despite the fact that B. bifidum is predicted to possess lacto-N-biosidase and galacto-N-
biosidase activity, enabling it to ferment HMOs (Wada et al., 2008), its relative abundance 
compared to other Bifidobacterium spp. groups was higher in adults and 2-year-old children 
than in newborns and 4-month-old infants. However, relative to the total bacterial load, this 
group of bacteria exhibited peak abundance at 4 months, when all infants were breast-fed, and 
became nearly absent in 2-year-olds and adults. Therefore, B. bifidum seems to be less 
affected by the total diminishing of Bifidobacterium spp. group than other species of this 
genus.  
The B. longum group was one of the two most abundant groups of Bifidobacterium species in 
1- and 2-year-old children and the third most abundant group in adults. In newborns B. 
longum comprised most of the Bifidobacterium spp. load. Compared to other Bifidobacterium 
species, B. longum showed the greatest correlation to outer bacterial groups as revealed by 
LSA, whereas B. breve, B. dentium and B. bifidum seemed to form a co-correlating triangle. 
Both B. longum and Lactobacillales were predicted to have a positive correlation to the 
Clostridium group, which may point to their interaction with these bacteria. Falony et al. 
(2006) studied the co-cultures of B. longum BB536 with Anaerostipes caccae or Roseburia 
intestinalis, both belonging to the Clostridium cluster. They have shown that when cultured 
on oligofructose as a sole carbon source, one of the Clostridium cluster species could not 
ferment oligofructose, whereas another was growing slowly. However, when B. longum was 
present in the system, both bacteria grew well by utilizing the acetate released by B. longum.  
The correlation detected in the work presented here, however, showed a comparative delay of 
three time points indicating that, apart from the feeding cross-pathway, the presence of B. 
longum during a mother’s pregnancy may by some means prepare the infant’s gut for the 
colonization with Clostridium species. Also, B. longum negatively correlated to 
Proteobacteria. We propose that this could be explained not by interactions between those 
two bacteria, but instead by the change in the environmental conditions. Proteobacteria are 
predominantly found among newborns, and then, when the oxygen in the gut becomes 
 66 
 
eliminated, Proteobacteria become outcompeted by strict anaerobes such as Bifidobacterium 
spp. It is worth noting, that the correlations revealed by LSA seem to be self-supportive, as 
bacterial groups which were found to be correlated with each other, had a similar correlation 
to a third bacterial group. Apart from the interaction between the Lactobacillalles, B. longum 
and Clostridium groups, this can also be demonstrated by the correlation between the 
abundances of B. breve, B. dentium and Faecalibacterium; between the B. longum, B. breve 
and Bacilli groups and between the B. longum, Bacilli and Proteobacteria. 
4.3 B. longum group resolution  
Despite the fact that B. longum longum is normally characteristic of an adult rather than of an 
infant gut, this species was detected in the majority of infants at all ages. Right after the birth, 
B. longum group was identified in 25 out of 32 children, and all sequences, apart from two 
that were unclassified, exclusively belonged to B. longum longum. The prevalence of the B. 
longum infantis group was quite low as it was detected only in 13 children, out of which 9 
were 4 months old. B. longum infantis is normally associated with a healthy infant microbiota 
and is believed to reduce the risk of allergy development as it suppresses pro-inflammatory 
IL-17 and induces anti-inflammatory IL-10 production (Miyauchi et al., 2010). In our study, 
we did not find any correlation between the presence of B. longum infantis in the stool 
samples and allergy development. However, we only used IgE levels as an indicator of allergy 
and not the IL-17/IL-10 ratio.  
Surprisingly, all sequences obtained from stool samples with the specific B. longum group 
primer were pure. In those children, who had B. longum infantis at 4 months, B. longum 
longum was detected earlier and later in life, suggesting a competition between the two 
species. B. longum longum is more suited for fermentation of plant-derived oligosaccharides, 
whereas B. longum infantis harbors breakdown machinery for milk-derived oligosaccharides  
(LoCascio et al., 2010). To check whether the reason we could not detect the co-existence of 
these two subspecies had been caused by infant diet, we incubated co-cultures of the two 
bacteria using lactose or lacto-N-biose as a single carbon source. The results, however, were 
inconclusive and the experiment has to be repeated with more stringent anaerobic conditions 
and better control of cell mixture concentrations. 
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4.4 Correlation to environmental factors 
To minimize the risk of false discovery, we assumed that if the development of some bacterial 
species is truly dependent on one or another factor, then it would be logical to expect a 
significant correlation of that factor to the abundance, to the change in the abundance or to 
both during some period of time rather than only at one time point. Also, the distribution of 
bacterial loadings can indicate whether or not the difference is real – if, graphically, the 
percentage represents a continuous line and both groups seem to be distributed evenly along 
this line, it is likely that even though the difference between two groups was found 
statistically significant, it might have no biological meaning.  
Factors related to the reported health status of the mother during pregnancy had the greatest 
correlation to the percentage and development of Bifidobacterium species. Whether or not the 
mother reported having had a cold during pregnancy seemed to correlate with significantly 
different levels of B. adolescentis, B. breve and B. longum at a given time point, whereas 
reporting of a vaginal fungal infection showed the greatest correlation to the change in the 
abundance of B. longum and all Bifidobacterium spp. group over time.  
People with weakened immune systems are more likely to exhibit symptoms of common cold 
infections (Cohen, S., 1996). IgA is the main immunoglobulin found in the mucous secretion 
of intestinal and respiratory tract (Wood, 2006) which prevents the penetration of pathogenic 
microorganisms by preventing their adsorption to mucosal epithelium. In line with this, B. 
breve, which is known for inducing serum IgA production (Yasui et al., 1992), was detected 
in significantly higher counts in the group of newborns whose mothers had not reported cold. 
Interestingly, both in 3- and 10-day-old infants, there was a clear separation between B. breve 
abundances in the two groups. It was especially evident at 10 days of age when almost all the 
infants of mothers who had reported a cold, had low B. breve counts, while its abundance in 
healthy group infants was high. Its increase in abundance from 10 days to 4 months was also 
higher in infants whose mothers had reported a cold. And then, by the age of 4 months, the 
amount of B. breve became significantly higher in this group of infants. However, at 2 years 
of age, relative amount of B. breve was higher in children of healthy mothers. The significant 
difference in the amount of B. breve at 2 years of age might indicate a long-term impact of a 
mother’s health on the gut microbiota of her child later in life. Taking into account the 
number of various time points where the significant correlation to the incidence of a reported 
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common cold was detected, it seems plausible that there is some mechanism behind, which 
may be connected both to the severity of cold symptoms and to the development of certain 
bifidobacterial species.  
For the most part, reported vaginal fungal infection correlated to the change in the abundance 
of Bifidobacterium species. Interestingly, out of 2 time points and 4 periods over time, during 
which the significant difference in B. longum group levels was detected between individuals, 
the all Bifidobacterium spp. group showed the same pattern at 1 time point and 3 periods over 
time. During pregnancy, both B. longum and all Bifidobacterium spp. groups increased in 
those mothers who reported having had a fungal infection and decreased in those, who had 
not. The same was observed in infants between 1 and 2 years of age. Interestingly, both B. 
longum and all Bifidobacterium spp. were lower in 1-year-old infants of mothers who had 
reported an infection. Also, both B. longum and all Bifidobacterium spp. groups increased to a 
higher extent in 3- to 10-day-old newborns whose mothers reported a fungal infection during 
pregnancy. The parallel correlation of Bifidobacterium spp. and B. longum to a reported 
fungal infection in children of various ages and the absence of this correlation to other 
bifidobacterial species might indicate that the change detected in all Bifidobacterium spp. was 
actually caused by the particular change in B. longum. However, during these developmental 
stages, B. longum does not constitute the majority of Bifidobacterium species in the gut. 
Moreover, even though at 10 days of age, the B. longum group constituted the majority of 
Bifidobacterium species, the abundance of B. longum in 10-day-old infants correlated to the 
reported incidence of vaginal fungal infection during pregnancy, but of all Bifidobacterium 
species did not. Similarly, both the abundances of all Bifidobacterium spp. and of B. 
adolescentis groups in newborns resembled that of the mother more in the no-infection group, 
whereas for B. longum a significant difference was not detected. Therefore the significant 
difference in the change of all Bifidobacterium spp. may mostly be explained by the change in 
the B. longum group, but it is also compensated by other bifidobacterial species to some 
extent. Vaginal fungal infection normally refers to Candida spp., a fungus which is a 
commensal intestinal resident, but causes an infection in vagina if the conditions, such as 
acidity and sugar content, are right (Janssen EMEA, 2011). In general, bifidobacterial flora is 
known to antagonize fungal infection (Romani, 2004). The observation that vaginal fungal 
infection correlated with changes in the abundances of bifidobacterial species over time might 
indicate that the immune system stimulates the growth of healthy microbiota as a response to 
the fungal infection. Unfortunately, we do not possess information on the treatment of women 
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who reportedly suffered from fungal infection. However, it is possible that pregnant women 
were advised to use vaginal suppositories containing lactobacilli and bifidobacteria. 
Both breast-feeding and multivitamin intake during the first year of life seemed, generally, to 
lead to elevated bifidobacterial counts in 1- and 2-year-old children. Intuitively, these results 
seem logical as all of the dominant bifidobacterial species are present in breast milk 
(Grönlund et al., 2007) and riboflavin, vitamin B2, is required for the growth of 
Bifidobacterium spp. (Rossi, Amaretti, 2010). However, in the case of breast-feeding, the 
significant difference seems to be caused only by 2 individuals who had high counts, whereas 
other infants had comparable levels of this species. As for multivitamin intake, the 
abundances of B. bifidum and B. longum were evenly distributed, regardless to which group 
infants belonged. Therefore, further confirmation of these results is required. 
We observed a very highly significant correlation between the percentage of B. breve at 10 
days and whether or not the children were given multivitamins later in life, with a very clear 
separation of the two groups. Obviously, the idea that a low B. breve percentage at 10 days 
would, in any way, make an impact on parents’ decision to give a multivitamin supplement to 
an infant few months later in life, is ridiculous. Most likely, this separation is caused not by 
the vitamin intake, but by some other factor, which coincidentally was observed in those 
children who were later given vitamins, and was absent in those who were not. We also 
detected a correlation between B. breve and B. bifidum abundance in infant guts and whether 
or not the mother had eaten vegetables regularly during pregnancy. However, this correlation 
was detected only at one age. Moreover, the abundances of B. bifidum in stool samples from 
infants formed an even distribution regardless mothers’ vegetable consumption. As for B. 
breve, even though it was nearly absent in infants whose mothers had been consuming 
vegetables on a nearly daily basis, whereas present in the other group, this separation might 
have actually been caused not by vegetable consumption, but by whether or not the mother 
reported having a cold during pregnancy, as these two factors were found cross-correlated to 
each other.  
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4.5 Correlation to allergy and eczema development 
The concentration of specific IgE in the serum was used for allergy assessment as, currently it 
is the most reliable immunological indicator (Størro et al., 2011). Three concentrations of IgE 
were considered – IgE ≥ 0.1 kU/l, 0.35 kU/l and 0.7 kU/l. Normally, the concentration of IgE 
≥ 0.35 kU/l indicates possible clinical allergy (Nevro-NEL, 2011). However, it still is just an 
indication, not the final diagnosis. Therefore for the discussion, we will focus on the 
correlation to IgE levels of more than 0.35 kU/l. The only consistent correlation of IgE levels 
to Bifidobacterium species was detected for B. adolescentis levels at 4 months of age and 
bordering periods over time. The relative amount of B. adolescentis was higher in 4-month-
old sensitized infants. From 10 days to 4 months of age, B. adolescentis increased in infants 
who had elevated IgE levels by the age of two years, while levels decreased in the non-
sensitized group. Conversely, from 4 months to 1 year of age, its levels increased in healthy, 
but decreased in allergic, children. This clear difference in the development of B. adolescentis 
over time may indicate that not the bacterial load itself, but changes of it may play role in, or 
be an indication of, allergy development.  
The symptoms of eczema include rash, itching and dryness which may also indicate allergy 
and can be misinterpreted by parents. Overall, there were five infants, each of whom had been 
diagnosed with allergy (IgE > 0.7 kU/l) and had eczema symptoms; in two of them eczema 
was confirmed by UKWP criteria. We find it very interesting that three of these 4-month-old 
infants, including two with medically confirmed eczema, had much higher abundance of B. 
adolescentis compared to other children. B. adolescentis has been isolated more frequently 
from stool samples of allergic children (Ouwehand et al, 2001; Stsepetova et al., 2007).  This 
species has been reported to trigger pro-inflammatory TNF-α, IL-6 and IL-12 cytokines, while 
it lacks the ability to induce anti-inflammatory IL-10 (He et al., 2002). In addition, B. 
adolescentis was shown to induce IL-5 which is also associated with atopic responses 
(Tannock, 2010). Taken together, this suggests that highly elevated levels of B. adolescentis 
around 4 months of age may be correlated to the development of a range of allergic disorders.  
UKWP-diagnosed eczema correlated to the abundance of B. longum load at 10 days and 1 
year of age and to the change in its abundance in newborns. In a recent study of Hong et al. 
(2010), higher abundances of B. longum were detected in 1-year-old non-eczema infants, but 
our data suggest the opposite. However, in Hong’s study, the correlation was detected among 
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caesarian-delivered children, whereas the B. longum abundance in stool samples from 
vaginally-delivered infants showed no correlation to eczema. Interestingly, for the IMPACT 
dataset, the abundance of all Bifidobacterium spp. was also found significantly higher in 1-
year-old infants with medically diagnosed eczema.  
4.6 Transmittance from mother to child 
We did not find correlation between the presence of a given bifidobacteria species in mothers 
with that in their newborns. For this test, we have binarized the data based on the percentage 
of the species in a given sample. However, the binarization approach is not the best way to 
test for the independence between two variables because of uncertainity regarding which 
threshold should be used. The only statistically justified threshold we could use was the 
estimated error of the MCR prediction. Unlike the detection threshold, the error of prediction 
does not imply that if the amount of the species is lower than this value, then the species will 
not be detected, it only implies is that if the real relative amount of the species is 10 % then 
the predicted amount may (or may not) deviate, in average, by 5 %. The best approach would 
be to look for the independence in actual, not binarized, data. A graphical representation of 
the percentage in mothers vs. the percentage in children clearly suggests that the presence of 
all five dominant bifidobacterial species is independent of that in the mothers. However, that 
still does not exclude the transmittance of bifidobacteria. We have to keep in mind that we 
have been analyzing only the stool samples. At birth, the child is exposed to bacteria which 
are present in the birth canal of the mother. Therefore vaginal swabs, but not stool samples, 
are more suitable for the analysis. Moreover, the child receives bifidobacteria during breast-
feeding as well – B. longum, B. animalis, B. bifidum, B. breve, B. adolescentis and B. 
catenulanum have been isolated from the breast milk (Grönlund et al., 2007). Additionally, 
bifidobacterial DNA have been detected in 8 out of 9 caesarian-delivered placenta samples 
raising a question about the sterility of the infant gut at birth (Satokari et al., 2009). On the 
other hand, dendritic cells supposedly transport bacteria from the gut to mother’s mammary 
glands (Perez et al., 2007) and the same mechanism might be used for the transmittance of 
bacteria (or alternatively bacterial DNA) to placenta. Therefore it may be still possible to 
show the transmittance from mother to child by assessing maternal gut microbiota.  
When we compared B. longum longum sequences in mother/child pairs, only four out of nine 
pairs had identical sequences. However, taking into account that apart from unclassified 
 72 
 
sequences, only B. longum longum was detected in both mothers’ and newborns’ stool 
samples, we believe that infants receive this species from their mothers. B. longum infantis 
was mostly detected at 4 months of age – there was only one sample where it was detected 
earlier. This indicates that B. longum infantis is most likely transmitted child-to-child and 
competes out B. longum longum as it is more suited for a milk diet (LoCascio et al., 2010). By 
the age of 1 year, however, when the change to a more adult-like diet occurs, B. longum 
longum regains its position and persists through life. There were only two infants where B. 
longum infantis persisted up to 1 year of age. Unfortunately for both infants, the 
questionnaires were not submitted and the information on their diet or lifestyles is absent. 
4.7 Suggestions of further work 
MCR is a promising approach for the analysis of mixed DNA samples; however, it would be 
beneficial to improve its predictability. We tested the possibility to use PLS regression for the 
correction of MCR predicted concentration profiles. This allowed diminishing the error of the 
concentration prediction in mixed samples and reducing the level of over- and 
underestimating some bacterial species. However, the PLS regression model has to be 
constructed for each specific dataset, so the researcher must be sure of the bacterial diversity 
in the dataset in question. This method might be a useful approach for concentration profile 
corrections when performing various co-culturing time series or, alternatively, when the 
bacterial diversity of the dataset is known in advance. 
The basecaller script designed in this project can also be improved. In case of mixed spectra 
with two peaks at one position, the basecaller calls for the IUPAC nucleotide ambiguity code, 
however, in case three peaks are mixed, the script assigns it not one, but instead two mixed 
nucleotides, which then requires manual correction. Also, when looking for the mixed peaks 
the basecaller script does not take into account the height ratio between these peaks. That 
means that if one of the peaks is slightly higher than the noise (e.g. 0.012 rfu), whereas the 
other is much higher (e.g. 0.08 rfu), the script would still assign a mixed nucleotide at this 
position. So implementation of both height ratio and three-mixed-peak nucleotide recognition 
would be a great improvement to the script. 
To further confirm the correct identification and quantification of dominant bifidobacterial 
species in stool samples, it is beneficial to perform the analysis with another gene. More 
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preferably, the full MLST should be performed on the data, not only to ensure the right 
identification of Bifidobacterium species, but also to examine the transmittance of these 
species by comparing the mother/child pairs. 
Moreover, it would be very interesting to isolate B. longum longum and B. longum infantis 
from IMPACT stool samples and perform a competition test with lacto-N-biose or, preferably 
purified HMOs, as a single carbon source to find out if the competition is driven solely by the 
diet. Our preliminary results on B. longum strains obtained from DSMZ collection suggest 
that B. longum longum DSM20219 outcompetes B. longum infantis DSM20088 at high cell 
densities, whereas it loses the competition at low cell concentration, which may point to their 
r/K selection. However, the experiment with each cell density was performed only once, so it 
should be repeated. 
IMPACT dataset has information on 720 individuals; we have analyzed only a small subset of 
it. We failed to determine correlations with regard to many environmental factors of interest, 
like pets at home or smoking parents, because there were not enough samples to separate 
groups into two. Therefore, it would be interesting to include more samples for the analysis to 
increase the strength of separation. Also, the questionnaires contained a lot of information on 
living conditions or health and diet both during pregnancy and the first year of life which we 
did not investigate due to time constraints. Therefore, it would also be interesting to increase 
the number of factors.  
In many studies, B. adolescentis has been detected more often in allergic infants. The 
consistent correlation of its abundance and the change in it around 4 months of age makes it 
very interesting to follow what happens during this period of development. Moreover, the 
extremely high abundance of B. adolescentis in three infants who had both high levels of IgE 
and eczema, raises even more interest in this bacterium. It would be very interesting to select 
more children with both high IgE and diagnosed and reported eczema to find out whether this 
extremely high abundance is a trend or a coincidence. If it is a trend, then it would be 
interesting to isolate B. adolescentis from the stool samples of these infants and perform the 
experiments with dendritic cells to see what cytokine profile is induced. 
Surprisingly, some Bifidobacterium species were consistently correlated to reports of having a 
common cold and vaginal fungal infection during pregnancy. To confirm the correlation 
findings, first we need to increase the number of samples. Also, we have not specified the 
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stage of the pregnancy when the infection occurred. Instead, we were solely concentrating on 
the fact that these diseases did or did not reportedly occur during pregnancy. However, the 
information about which trimester the women suffered from the disease is also available. 
Therefore it would be interesting to determine if the correlation of bifidobacterial species in 
infants with the occurrence or absence of these infections is independent of the pregnancy 
stage or not. If the correlation between the Bifidobacterium species composition and 
development is observed only if the cold or fungal infection happened at a single period, 
rather than during the entire pregnancy, then what happens during this particular period of 
time should be investigated. It would be of great interest to examine breast-milk samples from 
the mothers. It might be that both contracting a common cold and vaginal fungal infection 
during pregnancy may have an impact on the development of milk secretory cells, and the 
difference we see in infant’s stool samples is actually caused by the difference in the bacterial 
composition of the mother’s milk. Moreover, there was a positive cross-correlation between 
breast-feeding throughout the first year of life and allergy development. Therefore, it would 
also be interesting to see what changes in breast milk composition occur 1 year after the 
lactation starts.  
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5 Conclusion 
Five dominant Bifidobacterium species and their relative abundance were identified in stool 
samples of 83 infants of age 3 days, 10 days, 4 months, 1 year and 2 years and of their 
mothers during pregnancy. By the age of 10 days, B. adolescentis comprised the same relative 
amount of the total bacterial load in infant gut as in adults. Relative to Bifidobacterium spp., 
B. breve was the most abundant species in 4-month-old infants, whereas by the age of two 
years, stool samples were richest in B. longum, B. adolescentis and B. bifidum and the 
development of bifidobacterial microbiota was directed towards the adult profile. The B. 
longum group mostly consisted of B. longum longum irrespective of age, and B. longum 
infantis was mostly identified in 4-month-old individuals indicating the infant-to-infant nature 
of its transmittance. Possible interactions between B. longum and outer bacterial groups were 
revealed by LSA. Mother’s health status during pregnancy was found to be correlated to the 
composition and development of bifidobacterial microbiota of infants. The amount of B. 
breve in newborns, 4-month-old and 2-year-old infants correlated with the reported incidence 
of a common cold during pregnancy. The change in the relative amount of all Bifidobacterium 
spp. and the B. longum group in stool samples of infants during almost all age periods studied 
correlated to the reported occurrence of vaginal fungal infection during pregnancy. Elevated 
amounts of B. adolescentis in 4-month-old infants correlated to high IgE levels and eczema 
symptoms; levels of the B. longum group in infants correlated with the occurrence of eczema. 
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